prof. dr. johan denollet november 20, 1957, wilrijk, belgium corpsâ€“center of research on

CV Johan Denollet August 2015 - 1 -

Curriculum vitae

Personal details

Name: Prof. dr. Johan Denollet Date/place of birth: November 20, 1957, Wilrijk, Belgium Address: CoRPS–Center of Research on Psychology in Somatic diseases, Warandelaan 2,

5000 LE Tilburg, the Netherlands Email: [email protected] Lab: www.tilburguniversity.nl/corps/

Master's training

University: University of Ghent, Belgium, Graduation: October 02, 1980 Main subject: Developmental and Clinical Psychology

Doctorate

University: PhD, cum laude, University of Ghent, Belgium, Defence: July 8, 1992 Supervisors: Prof. dr. P. Van Oost (Ghent), Prof. dr. D.L. Brutsaert (Antwerp) Title of the thesis: “Personality, Rehabilitation and Coronary Heart Disease” Clinical work experience (1981 - 1999)

● 1991-1999 Medical Psychologist, 1.0 fte, tenured term, University Hospital of Antwerp, Belgium

● 1990-1991 Research Fellow, 1.0 fte, fixed 1 year-term, National Fund Scientific Research, Belgium

● 1983-1990 Medical Psychologist, 1.0 fte, tenured term, University Hospital of Antwerp, Belgium

● 1981 Psychologist, 1.0 fte, fixed-term, Social Services, City of Antwerp, Belgium

Academic work experience (2000 - )

● 2002 - Professor of Medical Psychology, tenured term, Tilburg University, the Netherlands

● 2000-2002 Associate Professor, tenured term Tilburg University, the Netherlands

● 2000-2004 Consultant liaison psychiatry, 0.1 fte, fixed-term, University Hospital of Maastricht

● 1999 - Visiting Professorship, Department of Medicine, University of Antwerp, Belgium

Function

- Director Research Institute CoRPS – Center of Research on Psychology in Somatic diseases,

Center of Excellence, Tilburg University (www.tilburguniversity.nl/corps/), 2014 - . - Head Department of Medical and Clinical Psychology, Tilburg University, 2002-2013.

- Consultant Department of Cardiology, University Hospital of Antwerp, Belgium 2000 - .

- Member of the CCMO (Central Committee on Research involving Human Subjects),

VWS, The Hague, the Netherlands, 2014 - .

Clinical expertise

In the years 1983-1999, I have been working in clinical practice as a medical psychologist at the University Hospital of Antwerp, Belgium, where I was involved in the clinical care of cardiac patients. During this period, I also completed a 3-year postgraduate training in behavioral therapy. In July 1990, I was granted a 1-year research fellowship by the Belgian National Fund for Scientific Research, Brussels

(1990-1991), and I successfully defended my PhD thesis in Psychology in 1992 (cum laude). Academic expertise: 2-year Master’s program in Medical Psychology

In 2000, at the age of 42, I made a major shift in my professional life and started my academic career

as an associate professor at Tilburg University, the Netherlands. Following my appointment as professor of medical psychology in 2002, I started with the development of a new 2-year master’s program in medical psychology. Eventually, I acquired accreditation from the Dutch Ministry of Education in 2005 to establish this unique master program which attracts students from all over the Netherlands. The training of students is based on the scientist-practitioner model and is provided by the scientific staff at Tilburg University as well as medical specialists and psychologists from collaborating teaching hospitals.

The Master’s program was evaluated and re-accredited in 2010 by the national independent review committee for higher education, which praised the program for its unique quality, as indicated by the following quotes: “The Medical Psychology program at Tilburg University sets an example for other university teaching programs”, ”The intensive collaboration between psychologists and medical doctors is unique and a valuable component of the program”, and “The program is solidly integrated into a research group of international standard.”

mailto:[email protected]

http://www.tilburguniversity.nl/corps/

http://www.tilburguniversity.nl/corps/


Academic expertise: Center of Excellence at Tilburg University

In 2008, I founded the Center of Research on Psychology in Somatic diseases (CoRPS) at Tilburg

University. The mission of CoRPS is to improve our understanding of the interface between mind and body, in order to achieve optimal health care for patients with medical or psychological conditions. The theoretical framework that drives the CoRPS research agenda is the biopsychosocial model of health, which is based on the notion that mind, body and social environment interact in causing disease. This has resulted in multiple high-quality projects and publications in the best journals in the fields of

psychology and medicine and the CoRPS research staff is internationally recognized for their expertise.

CoRPS was evaluated by an external committee (chaired by Prof. dr. J. de Haes, University of Amsterdam) for end-term quality and deliverables in 2013 which followed a successful mid-term review

(chaired by Prof. dr. J. Blumenthal from Duke University, Durham, NC) in 2011. Both committees were unambiguously positive about the achievements of CoRPS. In the end-term review, the committee emphasized its high standing: “CoRPS must be regarded as a leading center in clinically oriented medical psychological research at the European level’’. The mid-term committee concluded that “the quality of the research to be outstanding’’, “professor Denollet has assembled a superb team of investigators”, and “the worldwide recognition that it (CoRPS) has achieved is well-deserved.’’

In 2014, an expert panel appointed by the Board of Tilburg University and chaired by Prof. D. Breimer advised the board to award the qualification ‘Center of Excellence’ to CoRPS which was followed by the

official recognition as center of excellence. In their final report, the Breimer committee stated that “the quality of the CoRPS’ output is of very high level” and that “the research center ranks among the best

research institutes in its discipline internationally, with an international focus not only connecting psychology and the medical science, but also managing this for very different disease groups”.

Academic expertise: Psychological factors related to medical conditions

My research focuses on the interaction between behavioral factors (personality, emotions, stress) and

the development and progression of heart disease. This research includes a variety of methodological approaches, such as observational studies, intervention research in cardiology, research on biological and behavioral mechanisms of disease, large-scale research using panel data, questionnaire construction and validation, and studies on the generalizability of findings in an international context. Findings of this research indicated that Type D personality (which refers to the synergistic effect of two personality traits, negative affectivity and social inhibition) was associated with increased morbidity and

mortality in cardiac patients, and that this personality type comprises a risk marker on par with biomedical risk marker. Type D is also associated with adverse outcomes in patients with peripheral arterial disease and with disease-promoting inflammation in heart failure. My research also focuses on depression, anxiety and other psychological factors that relate to chronic disease disease.

Reviewing responsibilities for scientific journals

-The Lancet -Archives of General Psychiatry

-Circulation -Psychological Bulletin -Circulation: Cardiovascular Quality and Outcomes -Journal of Consulting and Clinical Psychology -Journal of the American College of Cardiology -Journal of Abnormal Psychology -European Heart Journal -Journal of Affective Disorders -Heart -Psychological Medicine -European Journal of Preventive Cardiology -Psychosomatic Medicine

-European Journal of Cardiovascular Surgery -Journal of Psychosomatic Research -European Journal of Cardiovascular Nursing -Journal of Behavioral Medicine -Journal of Cardiovascular Nursing -International Journal of Behavioral Medicine -Journal of Cardiopulmonary Rehabilitation -Health Psychology -European Journal of Personality -Journal of Health Psychology -Quality of Life Research -British Journal of Health Psychology -General Hospital Psychiatry -Psychology & Health

Organization of international meetings

- Program Committee, 60th Annual Meeting of the American Psychosomatic Society, March 2002. - Program Committee, Heart and Mind: International Conference on the Role of Stress in Coronary Heart Disease, Maastricht, the Netherlands, January 2003. - Program Committee, 61th Annual Meeting of the American Psychosomatic Society, Phoenix,AZ, USA, March 5-8, 2003. - Organizer of The 3th International Conference on Emotions in Health and Disease, Tilburg, The

Netherlands, October 19-21, 2003 - Program Committee, 62th Annual Meeting of the American Psychosomatic Society, Orlando,FL, USA, March 3-6, 2004 - Organizer of The 4th International Conference on Emotions in Health and Disease, Tilburg, The Netherlands, 22 – 24 October 2007


- Organizer of Emotions2011 - 5th International Conference on Emotions in Health and Disease, Tilburg, The Netherlands, 23 – 25 October 2011 - Organizer of Emotions2015 - The 6th International Conference on Emotions, Health and Well-being,

Tilburg, The Netherlands, October 2015

Supervisor of PhDs, Tilburg University

- I was the supervisor of the following PhD projects that were defended successfully:

1. Verkerk GJ, Postpartum depression: detection and prevention through interventions; March 2004

2. Aquarius AE, Patient-based outcomes in peripheral arterial disease; December 2005 3. Martens EJ, The complex nature of depression after acute myocardial infarction; May 2007 4. Schiffer AJ, Health outcomes in chronic heart failure: The role of Type D personality; April 2008 5. van den Broek KC, Anxiety and implantable defibrillator treatment; September 2008 6. Smith OR, Fatigue at the interface between body and mind in chronic heart failure; October 2009 7. Pelle AJ, The complexity of psychological factors in cardiac disease; October 2009

8. Smolderen KG, Psychological burden in peripheral arterial disease; October 2009 (PhD cum laude) 9. Versteeg H, Cardiovascular implantable electronic devices: The patient perspective (with Prof. S. Pedersen and Prof. P. Doevendans); November 2011 (cum laude) 10. Roest AM, Anxiety and depression in coronary heart disease: A closer look (with Prof. P. de Jonge); November 2011 (PhD cum laude)

11. Hoen P, New perspectives on depression and heart disease (with Prof. P. de Jonge); Sept. 2012 12. Svansdottír E, “Type D personality across general population and coronary patient samples in

Iceland: Implications for cardiovascular health”; November 2012 13. Bunevičius A, Mental distress and patient-centered outcomes in coronary disease; Novem. 2012 14. Nefs G, Diabetes and emotional distress: The need for a personalized approach (with Prof. F. Pouwer and Prof. V. Pop); May 2013 15. Van Zitteren M, Patient profiles and outcomes in lower-extremity peripheral arterial disease: Towards a patient-centered approach; September 2013. 16. Habibović M, Implantable cardioverter defibrillators–heart and mind (with Prof. S. Pedersen);

February 2014. 17. Brouwers C, Health status, psychological distress and inflammation in heart failure (with Prof. S. Pedersen); September 2014.

- I am currently the supervisor of the following ongoing PhD projects:

18. van Dooren F, Importance of depression, anxiety and Type D personality in the onset and course of type 2 diabetes (with Prof. F. Pouwer and Prof. F. Verhey); PhD defence planned in 2015 19. Kessing D, Psychological factors and adherence to treatment among patients with chronic heart failure; PhD defence planned in 2016

20. Van Montfoort E, Uncovering psychosocial stress as a risk marker in cardiac patients treated with percutaneous coronary intervention; PhD defence planned in 2017

Grants and funding as Professor of Medical Psychology

Research grant 2003, “Quality of life following dual-chamber pacing in heart failure”

(€ 60.000), Unrestricted grant, St Jude & Medtronic, The Netherlands. NHS grant 2004, “Psychological determinants of heart failure prognosis” (€

168.596), Research grant, Dutch Heart Foundation, The Netherlands. VICI grant 2005, “Personality and vulnerability to heart disease” (€ 1.250.000), ,

NWO-Netherlands Organization for Scientific Research, The Hague, The Netherlands. Funding (2008) of research center “CoRPS – Center of Research on Psychology in

Somatic diseases”, (€ 1.500.000), Board Tilburg University, Tilburg, The Netherlands. Recognition and funding (2014) of “Center of Excellence” CoRPS (€ 1.500.000),

Board Tilburg University, Tilburg, The Netherlands. Prizes

Marcel Vastesaeger Award 2002 “for outstanding research in the field of preventive cardiology” (€ 12.500), Belgian Society of Cardiology, Brussels, Belgium.

Huibregtsen Award 2007 “for research on science and society” (€ 25.000), Royal Dutch Academy of Sciences (KNAW), The Hague, The Netherlands.

Summary statistics on citations: (a) Web of Science and (b) Google Scholar (August 14, 2015)

Web of Science h-index = 42

Web of Science citations = 6.740

#Citations without self-citations = 5.341

Google Scholar h-index = 54

Google Scholar citations = 12.204

Google Scholar i10-index = 178


Examples of relevant publications, ranked by citations and impact factor (Web of Science)

●●●● citations >300; ●●● citations >200; ●● citations >100; ● citations >75

. 10 PUBLICATIONS IN PSYCHOLOGY / PSYCHIATRY JOURNALS .

●●●● IF= 4.0 Denollet J (2005). DS14: standard assessment of negative affectivity, social inhibition and Type D

personality. PSYCHOSOMATIC MEDICINE, 67: 89-97.

●● IF= 4.0 Denollet J, et al. (1995). Personality and mortality after myocardial infarction. PSYCHOSOMATIC

MEDICINE, 57:582-591.

●● IF= 2.8 Denollet J (2000). Type D personality – A potential risk factor refined. JOURNAL OF PSYCHOSOMATIC

RESEARCH, 49:255-266.

●● IF= 2.8 Emons WH, Meijer RR, Denollet J (2007). Negative affectivity and social inhibition in cardiovascular

disease: Evaluating Type D personality and its assessment using item response theory. JOURNAL OF PSYCHOSOMATIC RESEARCH, 63:27-39.

● IF= 6.1 Denollet J, et al. (2003). Cytokines and immune activation in systolic heart failure: the role of Type

D personality. BRAIN, BEHAVIOR AND IMMUNITY, 17:304-309.

● IF= 5.4 Denollet J (1993). Emotional distress and fatigue in coronary heart disease: the Global Mood Scale

(GMS). PSYCHOLOGICAL MEDICINE, 23:111-121.

● IF= 5.4 Martens EJ, Hoen PW, Mittelhaeuser M, de Jonge P, Denollet J (2010). Symptom dimensions of

post-myocardial infarction depression, disease severity and cardiac prognosis. PSYCHOLOGICAL MEDICINE, 40:807-814.

IF= 14.3 Denollet J (2013). Interpersonal sensitivity, social inhibition, and Type D personality: How and when are they associated with health? PSYCHOLOGICAL BULLETIN, 139:991-997.

IF= 9.3 Denollet J, et al. (2006). Recognizing increased risk of depressive comorbidity post-myocardial infarction: Looking for 4 symptoms of anxiety-depression (SAD4). PSYCHOTHERAPY AND PSYCHOSOMATICS, 57:346-352.

IF= 4.0 Denollet J, Pedersen SS, Vrints CJ, Conraads V (2013). Predictive value of social inhibition and

negative affectivity for cardiovascular events and mortality in patients with coronary artery disease: The Type D personality construct. PSYCHOSOMATIC MEDICINE, 75:873-881.

. 10 PUBLICATIONS IN CARDIOLOGY / MEDICAL JOURNALS .

●●●● IF= 39.2 Denollet J, et al. (1996). Personality as independent predictor of long-term mortality in patients

with coronary heart disease. THE LANCET, 347: 417-421.

●●● IF= 14.9 Denollet J, et al. (1998). Personality, disease severity and the risk of long-term cardiac events in

patients with a decreased ejection fraction after myocardial infarction. CIRCULATION, 97:167-173.

●●● IF= 14.9 Denollet J, et al. (2000). Inadequate response to treatment in coronary heart disease: adverse

effects of Type D personality and younger age. CIRCULATION, 102:630-635.

●● IF= 15.3 Strik JM, Denollet J, et al. (2003). Comparing symptoms of depression and anxiety as predictors

of cardiac events and increased health care consumption following myocardial infarction. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 42: 1801-1807.

●● IF= 15.3 Roest AM, Martens EJ, De Jonge P, Denollet J (2010). Anxiety and risk of incident coronary

heart disease: A meta-analysis. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 56:38-46.

●● IF= 5.0 Denollet J, et al. (2010). A general propensity to psychological distress affects cardiovascular

outcomes: Evidence from research on the Type D (distressed) personality profile. CIRCULATION: CARDIOVASCULAR QUALITY AND OUTCOMES, 3:546-557.

●● IF= 3.4 Denollet J, et al. (2006). Usefulness of Type D personality in predicting five-year cardiac events

above and beyond concurrent symptoms of stress in patients with coronary heart disease. AMERICAN JOURNAL OF CARDIOLOGY, 97: 970-973.

● IF= 14.9 Denollet J, et al. (2001). Reducing emotional distress improves prognosis in coronary heart

disease: 9-year mortality in a clinical trial of rehabilitation. CIRCULATION, 104:2018-2023.

● IF= 14.7 Denollet J, et al. (2006). Social inhibition modulates the effect of negative emotions on cardiac

prognosis following percutaneous coronary intervention in the drug-eluting stent era. EUROPEAN HEART JOURNAL, 27:171-177.

IF= 6.1 Denollet J, et al. (2013). Prognostic importance of distressed (Type D) personality and shocks in patients with an implantable cardioverter defibrillator. INTERNATIONAL JOURNAL OF CARDIOLOGY,

167:2705-2709.


List of publications (IF = Impact Factor 2013)

LEAD AUTHOR (International refereed journals)

1. Denollet J (1991). Negative affectivity and repressive coping: pervasive influence on self-reported mood, health, and coronary-prone behavior. PSYCHOSOMATIC MEDICINE, 53:538-556. (IF= 4.0)

2. Denollet J & De Potter B (1992). Coping subtypes for men with coronary heart disease: relationship to well-being, stress, and Type-A behavior. PSYCHOLOGICAL MEDICINE, 22:667-684. (IF= 5.4)

3. Denollet J (1993). The sensitivity of outcome assessment in cardiac rehabilitation. JOURNAL OF CONSULTING AND

CLINICAL PSYCHOLOGY, 61:686-695. (IF= 5.2)

4. Denollet J (1993). Emotional distress and fatigue in coronary heart disease: the Global Mood Scale (GMS). PSYCHOLOGICAL MEDICINE, 23:111-121. (IF= 5.4)

5. Denollet J (1993). Biobehavioral research on coronary heart disease: Where is the person? JOURNAL OF BEHAVIORAL

MEDICINE, 16:115-141. (IF= 2.8)

6. Denollet J (1994). Health complaints and outcome assessment in coronary heart disease. PSYCHOSOMATIC MEDICINE, 56:463-474. (IF= 4.0)

7. Denollet J & Brutsaert DL (1995). Enhancing emotional well-being by comprehensive rehabilitation in patients with coronary heart disease. EUROPEAN HEART JOURNAL, 16: 1070-1078. (IF= 14.7)

8. Denollet J, Sys SU & Brutsaert DL (1995). Personality and mortality after myocardial infarction. PSYCHOSOMATIC

MEDICINE, 57:582-591. (IF= 4.0)

9. Denollet J, Sys SU, Stroobant N, Rombouts H, Gillebert TC & Brutsaert DL (1996). Personality as independent predictor of long-term mortality in patients with coronary heart disease. THE LANCET, 347:417-421. (IF= 39.2)

10. Denollet J (1997). Personality, emotional distress, and coronary heart disease (invited review). EUROPEAN JOURNAL

OF PERSONALITY, 11:343-357. (IF= 1.9)

11. Denollet J & Brutsaert DL (1998). Personality, disease severity and the risk of long-term cardiac events in patients with a decreased ejection fraction after myocardial infarction. CIRCULATION, 97:167-173. (IF= 14.9)

12. Denollet J (1998). Personality and coronary heart disease: the Type D Scale-16 (DS16). ANNALS OF BEHAVIORAL

MEDICINE, 20:209-215. (IF= 3.6)

13. Denollet J (1998). Personality and risk of cancer in men with coronary heart disease. PSYCHOLOGICAL MEDICINE, 28:991-995. (IF= 5.4)

14. Denollet J (1999). Personality and cancer (review). CURRENT OPINION IN PSYCHIATRY, 12:743-748. (IF= 3.5)

15. Denollet J (2000). Type-D personality: A potential risk factor refined. JOURNAL OF PSYCHOSOMATIC RESEARCH, 49:255-266. (IF= 2.8)

16. Denollet J, Vaes J & Brutsaert DL (2000). Inadequate response to treatment in coronary heart disease: adverse effects of Type D personality and younger age on 5-year prognosis and quality of life. CIRCULATION, 102:630-35. (IF= 14.9)

17. Denollet J & Brutsaert DL (2001). Reducing emotional distress improves prognosis in coronary heart disease: 9-year mortality in a clinical trial of rehabilitation. CIRCULATION, 104:2018-2023. (IF= 14.9)

18. Denollet J & Van Heck GL (2001). Psychological risk factors in heart disease: What Type D personality is (not) about. JOURNAL OF PSYCHOSOMATIC RESEARCH, 51:465-468. (IF= 2.8)

19. Denollet J, Conraads VM, Brutsaert DL, De Clerck LS, Stevens WJ, Vrints CJ (2003). Cytokines and immune activation in systolic heart failure: the role of Type D personality. BRAIN, BEHAVIOR AND IMMUNITY, 17:304-309. (IF= 6.1)

20. Denollet J (2005). DS14: standard assessment of negative affectivity, social inhibition and Type D personality. PSYCHOSOMATIC MEDICINE, 67: 89-97. (IF= 4.0)

21. Denollet J, Pedersen SS, Ong AT, Erdman RA, Serruys PW, van Domburg RT (2006). Social inhibition modulates

the effect of negative emotions on cardiac prognosis following percutaneous coronary intervention in the drug-eluting stent era. EUROPEAN HEART JOURNAL, 27:171-177. (IF= 14.7)

22. Denollet J, Pedersen SS, Vrints CJ, Conraads VM (2006). Usefulness of type D personality in predicting five-year

cardiac events above and beyond concurrent symptoms of stress in patients with coronary heart disease. AMERICAN

JOURNAL OF CARDIOLOGY, 97: 970-973. (IF= 3.4)

23. Denollet J, De Vries J (2006). Positive and negative affect within the realm of depression, stress and fatigue: the two-factor distress model of the Global Mood Scale (GMS). JOURNAL OF AFFECTIVE DISORDERS, 91: 171-180. (IF= 3.7)


24. Denollet J, Strik JJ, Lousberg R, Honig A (2006). Recognizing increased risk of depressive comorbidity post-myocardial infarction: Looking for 4 symptoms of anxiety-depression (SAD4). PSYCHOTHERAPY AND PSYCHOSOMATICS, 57:346-352. (IF= 9.3)

25. Denollet J, Smolderen KGE, van den Broek KC, Pedersen SS (2007). The 10-item Remembered Relationship with Parents (RRP10) scale: two-factor model and association with adult depressive symptoms. JOURNAL OF AFFECTIVE

DISORDERS, 100:179-189. (IF= 3.7)

26. Denollet J, Holmes RVF, Vrints CJ, Conraads VM (2007). Unfavorable outcome of heart transplantation in recipients with a Type D personality. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 26:152-158. (IF= 5.6)

27. Denollet J, Kupper N (2007). Type-D personality, depression, and cardiac prognosis: Cortisol dysregulation as a mediating mechanism. JOURNAL OF PSYCHOSOMATIC RESEARCH, 62:607-609. (IF= 2.8)

28. Denollet J, Martens EJ, Nyklíček I, Conraads VM, de Gelder B (2008). Clinical events in coronary patients who report low distress: Adverse effect of repressive coping. HEALTH PSYCHOLOGY, 27: 302-308. (IF= 3.9)

29. Denollet J, Pedersen SS, Daemen J, de Jaegere PT, Serruys PW, van Domburg RT. (2008). Reduced positive affect (anhedonia) predicts major clinical events following implantation of coronary-artery stents. JOURNAL OF INTERNAL

MEDICINE, 263: 203-211. (IF= 5.7)

30. Denollet J, Pedersen SS (2008). Prognostic value of Type D personality compared with depressive symptoms. ARCHIVES OF INTERNAL MEDICINE, 110: 27-35. (IF= 13.2)

31. Denollet J, Vrints CJ, Conraads VM (2008). Comparing Type D personality and older age as correlates of tumor necrosis factor-alpha dysregulation in chronic heart failure. BRAIN, BEHAVIOR AND IMMUNITY, 22: 736-743. (IF= 6.1)

32. Denollet J (2008). Depression, anxiety, and trait negative affect as predictors of cardiac events: Ten years after. PSYCHOSOMATIC MEDICINE, 70:949-951. (IF=4.0)

33. Denollet J, Schiffer AA, Kwaijtaal M, Hooijkaas H, Hendriks EH, Widdershoven JW, Kupper N (2009). Usefulness of

Type D personality and kidney dysfunction as predictors of interpatient variability in inflammatory activation in chronic heart failure. AMERICAN JOURNAL OF CARDIOLOGY, 103:399-404. (IF=3.4)

34. Denollet J, Maas K, Knottnerus A, Keyzer JJ, Pop VJ (2009). Anxiety predicted premature all-cause and cardiovascular death in a 10-year follow-up of middle-aged women. JOURNAL OF CLINICAL EPIDEMIOLOGY, 62:452-456 . (IF= 5.4)

35. Denollet J, de Jonge P, Kuyper A, Schene AH, van Melle JP, Ormel J, Honig A (2009). Depression and Type D

personality represent different forms of distress in the Myocardial Infarction and Depression - Intervention Trial (MIND-IT). PSYCHOLOGICAL MEDICINE, 39:749-756. (IF=5.4)

36. Denollet J, Pedersen SS (2009). Anger, depression, and anxiety in cardiac patients: The complexity of individual differences in psychological risk. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 53:947-949. (IF= 15.3)

37. Denollet J, Martens EJ, Smith OR, Burg MM (2010). Efficient assessment of depressive symptoms and their prognostic value in myocardial infarction patients. JOURNAL OF AFFECTIVE DISORDERS, 120:105-111 . (IF=3.7)

38. Denollet J, Gidron Y, Vrints, CJ, Conraads, VM (2010). Anger, suppressed anger, and risk of adverse events in patients with coronary artery disease. AMERICAN JOURNAL OF CARDIOLOGY, 105:1555-1560. (IF=3.4)

39. Denollet J, Schiffer A, Spek V (2010). A general propensity to psychological distress affects cardiovascular outcomes: Evidence from research on the Type D (distressed) personality profile. CIRCULATION: CARDIOVASCULAR QUALITY AND

OUTCOMES, 3:546-557. (IF=5.0)

40. Denollet J, Conraads VM (2011). Type D personality and vulnerability to adverse outcomes in heart disease. CLEVELAND CLINIC JOURNAL OF MEDICINE, 78(Suppl 1):S13-S19. (IF= 3.3)

41. Denollet J (2012). Depression and distressed (Type D) personality: what is their impact on cardiovascular outcomes? DIALOGUES IN CARDIOVASCULAR MEDICINE, 17:115-125. (IF= - )

42. Denollet J, Tekle FB, van der Voort PH, Alings M, van den Broek KC (2013). Age-related differences in the effect

of psychological distress on mortality: Type D personality in younger older patients with cardiac arrhythmiasversus. BIOMEDICAL RESEARCH INTERNATIONAL, 2013, 246035. (IF= 2.7)

43. Denollet J, Kop WJ (2013). Personality factors, emotional triggers and acute cardiac events: A comment on Compare et al. ANNALS OF BEHAVIORAL MEDICINE, 45:273-275. (IF=3.6)

44. Denollet J, Freedland KE, Carney RM, de Jonge P, Roest AM (2013). Cognitive-affective symptoms of

depression after myocardial infarction: Different prognostic importance across age groups. PSYCHOSOMATIC

MEDICINE, 75:701-708. (IF= 4.0)

45. Denollet J, Pedersen SS, Vrints CJ, Conraads V (2013). Predictive value of social inhibition and negative

affectivity for cardiovascular events and mortality in patients with coronary artery disease: The Type D personality construct. PSYCHOSOMATIC MEDICINE, 75:873-881. (IF= 4.0)

46. Denollet J, Tekle FB, Pedersen SS, van der Voort PH, Alings M, van den Broek KC. (2013). Prognostic

importance of distressed (Type D) personality and shocks in patients with an implantable cardioverter defibrillator. INTERNATIONAL JOURNAL OF CARDIOLOGY, 167:2705-2709. (IF= 6.1)


47. Denollet J (2013). Interpersonal sensitivity, social inhibition, and Type D personality: How and when are they associated with health? PSYCHOLOGICAL BULLETIN, 139:991-997. (IF= 14.3)

48. Denollet J, Kupper N (2015). Stress and the heart: the role of Type D personality in personalized care. EUROPEAN

HEART JOURNAL, 36:1783-1785. (IF= 14.7)

LAST/SENIOR AUTHOR (International refereed journals)

49. Strik JM, Honig A, Lousberg R & Denollet J (2001). Sensitivity and specificity of observer and self-report questionnaires in major and minor depression following myocardial infarction. PSYCHOSOMATICS, 42:423-428. (IF= 1.6)

50. Pedersen SS, Denollet J (2002). Perceived health following myocardial infarction: Cross- validation of the Health Complaints Scale in Danish patients. BEHAVIOUR RESEARCH & THERAPY, 40:1221-1230. (IF= 3.8)

51. Nyklíček I, Vingerhoets A, Denollet J (2002). Emotional non-expression and health: Data, questions, and challenges (review). PSYCHOLOGY & HEALTH, 17:517-528. (IF= 2.1)

52. De Fruyt F, Denollet J (2002). Type D personality: a Five-Factor Model perspective (invited article). PSYCHOLOGY &

HEALTH, 17:671-683. (IF= 2.1)

53. Pedersen SS, Denollet J (2003). Type D personality, cardiac events, and impaired quality of life: a review. EUROPEAN

JOURNAL OF CARDIOVASCULAR PREVENTION AND REHABILITATON, 10:241-248. (IF= 2.6)

54. Pedersen SS, Denollet J (2004). Validity of the Type D personality construct in Danish post-MI patients and healthy controls. JOURNAL OF PSYCHOSOMATIC RESEARCH, 57: 265-272. (IF= 2.8)

55. Schiffer AA, Pedersen SS, Widdershoven JW, Hendriks EH, Winter JB, Denollet J (2005). The distressed (type D)

personality is independently associated with impaired health status and increased depressive symptoms in chronic heart failure. EUROPEAN JOURNAL OF CARDIOVASCULAR PREVENTION AND REHABILITATON, 12:341-346. (IF= 2.6)

56. Pedersen SS, Denollet J (2006). Is Type D personality here to stay? Emerging evidence across cardiovascular disease patient groups. CURRENT CARDIOLOGY REVIEWS, 2:205-213. (IF= - )

57. Emons WH, Meijer RR, Denollet J (2007). Negative affectivity and social inhibition in cardiovascular disease: Evaluating Type D personality and its assessment using item response theory. JOURNAL OF PSYCHOSOMATIC RESEARCH, 63:27-39. (IF= 2.8)

58. Martens EJ, Smith ORF, Denollet J (2007). Psychological symptom clusters, psychiatric comorbidity and poor health status following myocardial infarction. ANNALS OF BEHAVIORAL MEDICINE, 34,87-94. (IF= 3.6)

59. Gidron Y, Kupper N, Kwaijtaal M, Winter J, Denollet J (2007). Vagus-brain communication in atherosclerosis-related inflammation: A neuroimmunomodulation perspective of CAD. ATHEROSCLEROSIS, 195(2):e1-9. (IF= 3.9)

60. Smith ORF, Michielsen HJ, Pelle AJ, Schiffer AA, Winter JB, Denollet J (2007). Symptoms of fatigue in chronic heart failure patients: Clinical and psychological predictors. EUROPEAN JOURNAL OF HEART FAILURE, 9:922-927. (IF= 6.5)

61. Martens EJ, Kupper N, Pedersen SS, Aquarius AE, Denollet J (2007). Type-D personality is a stable taxonomy in post-MI patients over an 18-month period. JOURNAL OF PSYCHOSOMATIC RESEARCH, 63:545-550. (IF= 2.8)

62. Kupper N, Denollet J (2007). Type-D personality as a prognostic factor in heart disease: Assessment and mediating mechanisms. JOURNAL OF PERSONALITY ASSESSMENT, 89: 265-276. (IF= 2.0)

63. Smolderen KG, Vingerhoets AJ, Croon MA, Denollet J (2007). Personality, psychological stress, and self-reported influenza symptomatology. BMC PUBLIC HEALTH, 7: 339. (IF= 2.3)

64. Schiffer AA, Pedersen SS, Broers H, Widdershoven JW, Denollet J (2008). Type-D personality but not depression

predicts severity of anxiety in heart failure patients at 1-year follow-up. JOURNAL OF AFFECTIVE DISORDERS, 106: 73-81. (IF= 3.7)

65. Smolderen KG, Aquarius AE, de Vries J, Smith ORF, Hamming JF, Denollet J (2008). Depressive symptoms in peripheral arterial disease: a follow-up study on prevalence, stability, and risk factors. JOURNAL OF AFFECTIVE

DISORDERS, 110: 27-35. (IF= 3.7)

66. Pedersen SS, Smith ORF, De Vries J, Appels A, Denollet J (2008). Course of anxiety symptoms over an 18-month period in exhausted patients post percutaneous coronary intervention. PSYCHOSOMATIC MEDICINE, 70: 349-355. (IF= 4.0)

67. Pelle AJ, Gidron YY, Szabó BM, Denollet J (2008). Psychological predictors of prognosis in chronic heart failure. JOURNAL OF CARDIAC FAILURE, 14: 341-350. (IF= 3.0)

68. de Gelder B, van de Riet WA, Grèzes J, Denollet J (2008). Decreased differential activity in the amygdala in response to fearful expressions in Type D personality. CLINICAL NEUROPHYSIOLOGY, 38:163-169. (IF= 1.4)

69. Smolderen KG, Aquarius AE, Denollet J (2008). Depression and screening cardiovascular events. JOURNAL OF

GENERAL INTERNAL MEDICINE, 2008, 23:1543. (IF= 3.4)

70. van den Broek KC, Nyklícek I, Van der Voort PH, Alings M, Denollet J (2008). Shocks, personality, and anxiety in patients with an implantable defibrillator. PACING AND CLINICAL ELECTROPHYSIOLOGY, 31:850-857. (IF= 1.2)


71. Schiffer AA, Pedersen SS, Widdershoven JW, Denollet J (2008). Type D personality and depressive symptoms are independent predictors of impaired health status in chronic heart failure. EUROPEAN JOURNAL OF HEART FAILURE, 10:802-810. (IF= 6.5)

72. Smith OR, Pedersen SS, Van Domburg RT, Denollet J (2008). Symptoms of fatigue and depression in ischemic

heart disease are driven by personality characteristics rather than disease stage: a comparison of CAD and CHF patients. EUROPEAN JOURNAL OF CARDIOVASCULAR PREVENTION AND REHABILITATION, 15: 583-588. (IF= 2.6)

73. Smith OR, van den Broek KC, Renkens M, Denollet J (2008). Comparison of fatigue levels in patients with stroke

and patients with end-stage heart failure: application of the fatigue assessment scale. JOURNAL OF THE AMERICAN

GERIATRICS SOCIETY, 56: 1915-1919. (IF= 4.2)

74. Pedersen SS, Yagensky A, Smith ORF, Yagenska O, Shpak V, Denollet J (2009). Preliminary evidence for the cross-cultural utility of the Type D personality construct in the Ukraine. INTERNATIONAL JOURNAL OF BEHAVIORAL

MEDICINE, 16:108-115. (IF= 2.2)

75. Pelle AJ, Pedersen SS, Szabó BM, Denollet J (2009). Beyond Type D personality: Reduced positive affect (anhedonia) predicts impaired health status in chronic heart failure. QUALITY OF LIFE RESEARCH, 18: 689-698. (IF= 2.8)

76. Aquarius AE, Smolderen KG, Hamming JF, De Vries J, Vriens PW, Denollet J. (2009). Type D personality and mortality in peripheral arterial disease: a pilot study. ARCHIVES OF SURGERY, 144:728-733. (IF= 4.2)

77. van den Broek KC, Nyklíček I, Denollet J (2009). Anxiety predicts poor perceived health in patients with an implantable defibrillator. PSYCHOSOMATICS, 50:483-492. (IF= 1.6)

78. Pedersen SS, Spinder H, Erdman RAM, Denollet J (2009). Poor perceived social support in implantable

cardioverter defibrillator (ICD) patients and their partners: Cross-validation of the Multidimensional Scale of Perceived Social Support. PSYCHOSOMATICS, 50:461-467. (IF= 1.6)

79. Smith OR, Gidron Y, Kupper N, Winter JB, Denollet J (2009). Vital exhaustion in chronic heart failure: symptom profiles and clinical outcome. JOURNAL OF PSYCHOSOMATIC RESEARCH, 66:195-201. (IF= 2.8)

80. Soons P, Denollet J (2009). Medical psychology services in dutch general hospitals: state of the art developments and recommendations for the future. JOURNAL OF CLINICAL PSYCHOLOGY IN THE MEDICAL SETTINGS, 16:161-168. (IF= 1.5)

81. Nyklícek I, Denollet J (2009). Development and evaluation of the Balanced Index of Psychological Mindedness (BIPM). PSYCHOLOGICAL ASSESSMENT, 21:32-44. (IF= 2.8)

82. Smolderen KG, Pelle AJ, Kupper N, Mols F, Denollet J (2009).Impact of peripheral arterial disease on health status: a comparison with chronic heart failure. JOURNAL OF VASCULAR SURGERY, 50:1391-1398. (IF= 2.9)

83. Kupper, HM, Gidron Y, Winter J, Denollet J (2009). Association between Type D personality, depression, and oxidative stress in patients with chronic heart failure. PSYCHOSOMATIC MEDICINE, 71:973-980. (IF= 4.0)

84. van den Broek KC, Nyklíček I, Van der Voort PH, Alings M, Meijer A, Denollet J (2009). Risk of ventricular arrhythmia after implantable defibrillator treatment in anxious Type D patients. JOURNAL OF THE AMERICAN COLLEGE

OF CARDIOLOGY, 54:531-537. (IF= 15.3)

85. Martens EJ, Hoen PW, Mittelhaeuser M, de Jonge P, Denollet J (2010). Symptom dimensions of post-myocardial infarction depression, disease severity and cardiac prognosis. PSYCHOLOGICAL MEDICINE, 40:807-814. (IF= 5.4)

86. Mols F, Martens EJ, Denollet J (2010). Type D personality and depressive symptoms are independent predictors of impaired health status following acute myocardial infarction. HEART, 96:30-35. (IF= 6.0)

87. Mols F, Denollet J (2010). Type D personality among noncardiovascular patient populations: a systematic review. GENERAL HOSPITAL PSYCHIATRY, 32:66-72. (IF= 2.8)

88. Smith OR, Kupper H, De Jonge P, Denollet J (2010). Distinct trajectories of fatigue in chronic heart failure and their association with prognosis. EUROPEAN JOURNAL OF HEART FAILURE, 12:841-848. (IF= 6.5)

89. van den Broek KC, Smolderen KG, Pedersen SS Denollet J (2010). Type D Personality mediates the relationship between remembered parenting and perceived health. PSYCHOSOMATICS, 51:216-224. (IF= 1.6)

90. Pelle AJ, Pedersen SS, Schiffer AA, Szabó B, Widdershoven JW, Denollet J (2010). Psychological distress and mortality in systolic heart failure. CIRCULATION: HEART FAILURE, 3:261-267. (IF= 5.9)

91. Mols F, Denollet J (2010). Type D personality in the general population: a systematic review of health status, mechanisms of disease, and work-related problems. HEALTH AND QUALITY OF LIFE OUTCOMES, 8:9. (IF= 2.1)

92. Mommersteeg PM, Kupper N, Denollet J (2010). Type D personality is associated with increased metabolic syndrome prevalence and an unhealthy lifestyle in a cross-sectional Dutch community sample. BMC PUBLIC

HEALTH, 19;10:714. (IF= 2.3)

93. Yu DS, Thompson DR, Yu CM, Pedersen SS, Denollet J (2010). Validating the Type D personality construct in Chinese patients with coronary heart disease. JOURNAL OF PSYCHOSOMATIC RESEARCH, 69:111-118. (IF= 2.8)


94. Pelle AJ, Schiffer AA, Smith OR, Widdershoven JW, Denollet J (2010). Inadequate consultation behavior

modulates the relationship between Type D personality and impaired health status in chronic heart failure. INTERNATIONAL JOURNAL OF CARDIOLOGY, 142:65-71. (IF= 6.1)

95. Schiffer AA, Smith OR, Pedersen SS, Widdershoven JW, Denollet J (2010). Type D personality and cardiac mortality in patients with chronic heart failure. INTERNATIONAL JOURNAL OF CARDIOLOGY, 142:230-235. (IF= 6.1)

96. Martens EJ, Mols F, Burg MM, Denollet J (2010). Type D personality predicts clinical events after myocardial infarction, above and beyond disease severity and depression. JOURNAL OF CLINICAL PSYCHIATRY, 71:778-783. (IF= 5.1)

97. Roest AM, Martens EJ, De Jonge P, Denollet J (2010). Anxiety and risk of incident coronary heart disease: A meta-analysis. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 56:38-46. (IF= 15.3)

98. Smolderen KG, Spertus JA, Vriens PW, Kranendonk S, Nooren M, Denollet J (2010). Younger women with symptomatic peripheral arterial disease are at increased risk of depressive symptoms. JOURNAL OF VASCULAR

SURGERY, 52(3):637-644. (IF= 2.9)

99. van den Broek KC, Nyklíček I, Denollet J (2011). Selection bias in a study of implantable defibrillator patients: the role of Type D personality. INTERNATIONAL JOURNAL OF BEHAVIORAL MEDICINE, 18:65-70. (IF= 2.2)

100. Pedersen SS, Broek KC, Theuns DAMJ, Erdman RA, Alings M, Meijer A, Jordaens L, Denollet J (2011). Risk of chronic anxiety in implantable defibrillator patients: a multi-center study. INTERNATIONAL JOURNAL OF CARDIOLOGY, 147:420-423. (IF= 6.1)

101. Lim HE, Lee MS, Ko YH, Park YM, Joe SH, Kim YK, Han C, Lee HY, Pedersen SS, Denollet J (2011). Assessment of the type D personality construct in the Korean population: a validation study of the Korean DS14. JOURNAL OF

KOREAN MEDICAL SCIENCE, 26:116-123. (IF= 1.2)

102. Pelle AJ, Pedersen SS, Erdman RA, Kazemier M, Spiering M, van Domburg RT, Denollet J (2011). Anhedonia

is associated with poor health status and more somatic and cognitive symptoms in patients with coronary artery disease. QUALITY OF LIFE RESEARCH, 20:643-651. (IF= 2.8)

103. Nyklíček I, Vorselaars A, Denollet J (2011). Type D personality and cardiovascular function in daily life of people without documented cardiovascular disease. INTERNATIONAL JOURNAL OF PSYCHOPHYSIOLOGY, 80:139-142. (IF= 2.6)

104. Tully PJ, Pedersen SS, Winefield HR, Baker RA, Turnbull DA, Denollet J (2011). Cardiac morbidity risk and

depression and anxiety: a disorder, symptom and trait analysis among cardiac surgery patients. PSYCHOLOGY, HEALTH AND MEDICINE, 16:333-345. (IF= 1.5)

105. Huis in ’t Veld EM, Vingerhoets AJ, Denollet J (2011). Attachment style and self-esteem: The mediating role of Type D personality. PERSONALITY AND INDIVIDUAL DIFFERENCES, 50:1099–1103. (IF= 1.8)

106. Svansdottir E, van den Broek KC, Karlsson HD, Gudnason T, Denollet J (2012). Type D personality is associated

with impaired psychological status and unhealthy lifestyle in Icelandic cardiac patients: A cross-sectional study. BMC PUBLIC HEALTH, 12(1):42. (IF= 2.3)

107. Emons WH, Mols F, Pelle A, Smolderen KG, Denollet J (2012). Type D Assessment in patients with chronic heart

failure and peripheral arterial disease: evaluation of the experimental DS(3) scale using Item Response Theory. JOURNAL OF PERSONALITY ASSESSMENT, 94(2):210-219. (IF= 2.0)

108. Mols F, Thong MS, van de Poll-Franse LV, Roukema JA, Denollet J (2012). Type D (distressed) personality is associated with poor quality of life and mental health among 3080 cancer survivors. JOURNAL OF AFFECTIVE

DISORDERS, 136:26-34. (IF= 3.7)

109. Kupper N, Denollet J (2012). Social anxiety in the general population: introducing abbreviated versions of SIAS and SPS. JOURNAL OF AFFECTIVE DISORDERS, 136:90-98. (IF=3.7)

110. Pelle AJ, Loerbroks A, Widdershoven JW, Denollet J (2012). Heart failure and comorbid diabetes mellitus or chronic obstructive pulmonary disease: Effects on mood in outpatients. INTERNATIONAL JOURNAL OF CARDIOLOGY, 154:216-217. (IF= 6.1)

111. Svansdottir E, Karlsson HD, Gudnason T, Olason DT, Thorgilsson H, Sigtryggsdottir U, Sijbrands EJ, Pedersen SS, Denollet J (2012). Validity of Type D personality in Iceland: association with disease severity and risk markers in cardiac patients. JOURNAL OF BEHAVIORAL MEDICINE, 35:155-166. (IF= 2.8)

112. Habibović M, van den Broek KC, Alings M, Van der Voort PH, Denollet J (2012). Posttraumatic stress 18 months following cardioverter defibrillator implantation: Shocks, anxiety, and personality. HEALTH PSYCHOLOGY, 31:186-193. (IF= 3.9)

113. Nefs G, Pouwer F, Pop V, Denollet J (2012). Type D (distressed) personality in primary care patients with type 2 diabetes: Validation and clinical correlates of the DS14 assessment. JOURNAL OF PSYCHOSOMATIC RESEARCH, 72:251-257. (IF= 2.8)

114. Smith OR, Kupper N, Schiffer AA, Denollet J (2012). Somatic depression predicts mortality in chronic heart failure:

Can this be explained by co-varying symptoms of fatigue? PSYCHOSOMATIC MEDICINE, 74:459-463. (IF= 4.0)


115. Versteeg H, Spek V, Pedersen SS, Denollet J (2012). Type D personality and health status in cardiovascular disease populations: a meta-analysis of prospective studies. EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY, 19:1373-1380. (IF=2.6)

116. Brouwers CJ, Mommersteeg PM, Nyklicek I, Pelle AJ, Westerhuis BL, Szabó BM, Denollet J (2013). Positive

affect dimensions and their association with inflammatory biomarkers in patients with chronic heart failure. BIOLOGICAL PSYCHOLOGY, 92 (2), 220-226. (IF= 3.4)

117. Bunevicius A, Staniute M, Brozaitiene J, Stropute D, Bunevicius R, Denollet J (2013). Type D (distressed) personality and its assessment with the DS14 in Lithuanian patients with coronary artery disease. JOURNAL OF

HEALTH PSYCHOLOGY, 18 (9), 1242-1251. (IF= 1.8)

118. Habibović M, Pedersen SS, van den Broek KC, Theuns DA, Jordaens L, van der Voort PH, Alings M, Denollet J

(2013). Anxiety and the risk of ventricular arrhythmias or mortality in patients with an implantable cardioverter defibrillator. PSYCHOSOMATIC MEDICINE, 75 (1), 36-41. (IF= 4.0)

119. Kupper N, Pedersen SS, Höfer S, Saner H, Oldridge N, Denollet J (2013). Cross-cultural analysis of Type D

(distressed) personality in 6222 patients with ischemic heart disease: A study from the International HeartQoL Project. INTERNATIONAL JOURNAL OF CARDIOLOGY, 166 (2), 327-333. (IF= 6.1)

120. Kupper N, Pelle AJ, Denollet J (2013). Association of Type D personality with the autonomic and hemodynamic response to the cold pressor test. PSYCHOPHYSIOLOGY, 50 (12), 1194-1201. (IF= 3.1)

121. Kupper N, Pelle AJ, Szabó BM, Denollet J (2013). The relationship between Type D personality, affective symptoms and hemoglobin levels in chronic heart failure. PLOS ONE, 8 (3), 58370-. (IF= 3.5)

122. Kupper N, van den Broek KC, Widdershoven JW, Denollet J (2013). Subjectively reported symptoms in patients with persistent atrial fibrillation and emotional distress. FRONTIERS IN PSYCHOLOGY FOR CLINICAL SETTINGS, 4, 192-. (IF= 2.8)

123. Nyklíček I, van Beugen S, Denollet J (2013). Effects of mindfulness-based stress reduction on distressed (Type D) personality traits: A randomized controlled trial. JOURNAL OF BEHAVIORAL MEDICINE, 36 (4), 361-370. (IF= 2.8)

124. Svansdóttir E, van den Broek KC, Karlsson HD, Olason DT, Thorgilsson H, Denollet J (2013). The distressed

(Type D) and Five-Factor Models of personality in young, healthy adults and their association with emotional inhibition and distress. PERSONALITY AND INDIVIDUAL DIFFERENCES, 55, 123-128. (IF= 1.8)

125. van den Broek KC, Tekle FB, Habibovic M, Alings M, van der Voort PH, Denollet J. (2013). Emotional distress,

positive affect, and mortality in patients with an implantable. INTERNATIONAL JOURNAL OF CARDIOLOGY, 165 (2), 327-332. (IF= 6.1)

126. Brouwers C, Kupper N, Pelle AJ, Szabó BM, Westerhuis BL, Denollet J (2014). Depressive symptoms in

outpatients with heart failure: importance of inflammatory biomarkers, disease severity and personality. PSYCHOLOGY & HEALTH, 29:564-582. (IF= 2.1)

127. Bunevicius A, Brozaitiene J, Staniute M, Gelziniene V, Duoneliene I, Pop VJ, Bunevicius R, Denollet J (2014).

Decreased physical effort, fatigue, and mental distress in patients with coronary artery disease: importance of personality-related differences. INTERNATIONAL JOURNAL OF BEHAVIORAL MEDICINE, 21:240-247. (IF= 2.2)

128. Kupper N, Denollet J (2014). Type D personality is associated with social anxiety in the general population. INTERNATIONAL JOURNAL OF BEHAVIORAL MEDICINE, 21:496-505. (IF= 2.2)

129. Habibović M, Pedersen SS, van den Broek KC, Denollet J (2014). Monitoring treatment expectations in patients with an implantable cardioverter-defibrillator using the EXPECT-ICD scale. EUROPACE, 16:1022-1027. (IF= 3.0)

130. Kessing D, Pelle AJ, Kupper N, Szabó BM, Denollet J (2014). Positive affect, anhedonia, and compliance with self-care in patients with chronic heart failure. JOURNAL OF PSYCHOSOMATIC RESEARCH, 77:296-301. (IF= 2.8)

131. Roest AM, Heideveld A, Martens EJ, de Jonge P, Denollet J (2014). Symptom dimensions of anxiety following

myocardial infarction: associations with depressive symptoms and prognosis. HEALTH PSYCHOLOGY, 33:1468-1476. (IF= 3.9)

132. Versteeg H, Roest AM, Denollet J (2015). Persistent and fluctuating anxiety levels in the 18 months following acute myocardial infarction: the role of personality. GENERAL HOSPITAL PSYCHIATRY, 37:1-6. (IF= 2.8)

133. Nefs G, Speight J, Pouwer F, Pop V, Bot M, Denollet J (2015). Type D personality, suboptimal health behaviors and emotional distress in adults with diabetes: Results from Diabetes MILES - The Netherlands. DIABETES

RESEARCH AND CLINICAL PRACTICE, 108:94-105. (IF= 2.5)

134. Mommersteeg PM, Widdershoven JW, Aarnoudse W, Denollet J (2015). Personality subtypes and chest pain in

patients with nonobstructive coronary artery disease from the TweeSteden Mild Stenosis study: mediating effect of anxiety and depression. EUROPEAN JOURNAL OF PAIN, 00:000-000, in press. [Epub ahead of print: doi: 10.1002/ejp.743] (IF= 2.9)

SECOND AUTHOR (International refereed journals)

135. Conraads VM, Denollet J, Vorlat A, Moulijn AC, Vrints CJ (2001). Screening for solid organ malignancies prior to heart transplantation. TRANSPLANTATION, 71:1481-1483. (IF= 3.5)


136. Ketterer MW, Denollet J, Goldberg AD, McCullough PA, John S, Farha AJ, Clark V, Keteyian S, Chapp J, Thayer B,

Deveshwar S (2002). The big mush: psychometric measures are confounded and non-independent in their association with age at initial diagnosis of ischaemic coronary heart disease. JOURNAL OF CARDIOVASCULAR RISK, 9:41-48. (IF= 2.6)

137. Aben IJ, Denollet J, Lousberg R, Verhey F, Wojciechowski F, Honig A (2002). Personality as a vulnerability factor for depression in post-stroke patients. STROKE, 33:2391-2395. (IF= 6.0)

138. Strik JM, Denollet J, Lousberg R, Honig A (2003). Comparing symptoms of depression and anxiety as predictors of cardiac events and increased health care consumption following myocardial infarction. JOURNAL OF THE AMERICAN

COLLEGE OF CARDIOLOGY, 42: 1801-1807. (IF= 15.3)

139. Kuijpers PM, Denollet J, Lousberg R, Wellens HJ, Crijns H, Honig A (2003). Validity of the Hospital Anxiety Depression Scale for use with patients with noncardiac chest pain. PSYCHOSOMATICS, 44:329-335. (IF= 1.6)

140. Ketterer MW, Denollet J, Chapp J, Thayer B, Keteyian S, Clark V, John S, Farha AJ, Deveshwar S (2004). Men deny and women cry, but who dies? Do the wages of “denial” include early ischaemic coronary heart disease? JOURNAL OF

PSYCHOSOMATIC RESEARCH, 56:119-123. (IF= 2.8)

141. Verkerk GJ, Denollet J, Van Heck GL, Van Son MJ, Pop VJ (2004). Patient preference for counseling predicts postpartum depression: A prospective 1-year follow-up study in high-risk women. JOURNAL OF AFFECTIVE DISORDERS, 83: 43-48. (IF= 3.7)

142. Ketterer MW, Denollet J, Chapp J, Keteyian S, Farha AJ, Clark V, Hudson M, Hakim A, Greenbaum A, Schairer J,

Cao JJ (2004). Familial transmissibility of early age at initial diagnosis in coronary heart disease (CHD). JOURNAL OF

BEHAVIORAL MEDICINE, 27:1-10. (IF= 2.8)

143. Verkerk GJ, Denollet J, Van Heck GL, Van Son MJ, Pop VJ (2005). Personality factors as determinants of depression in postpartum women: A prospective 1-year follow-up study. PSYCHOSOMATIC MEDICINE, 67: 632-637. (IF= 4.0)

144. Aquarius AE, Denollet J, Hamming JF, Breek JC, De Vries J (2005). Impaired health status and invasive treatment in peripheral arterial disease: a prospective one-year follow-up study. JOURNAL OF VASCULAR SURGERY, 41: 436-442. (IF= 2.9)

145. Aquarius AE, Denollet J, Hamming JF, De Vries J (2005). Role of disease status and type D personality in outcomes in patients with peripheral arterial disease. AMERICAN JOURNAL OF CARDIOLOGY, 96: 996-1001. (IF= 3.4)

146. Martens EJ, Denollet J, Pedersen SS, Scherders M, Griez E, Widdershoven J, Szabó B, Bonnier H, Appels A (2006). Relative lack of depressive cognitions in post-myocardial infarction depression. JOURNAL OF AFFECTIVE DISORDERS, 94:231-237. (IF= 3.7)

147. Aquarius AE, Denollet J, Hamming JF, De Vries J (2006). Age-related differences in invasive treatment of peripheral arterial disease: disease severity versus social support as determinants. JOURNAL OF PSYCHOSOMATIC RESEARCH, 61:739-745. (IF= 2.8)

148. van den Broek KC, Denollet J, Nyklicek I, van der Voort PH (2006). Psychological reaction to potential malfunctioning of implantable defibrillators. PACING AND CLINICAL ELECTROPHYSIOLOGY, 29:953-956. (IF= 1.2)

149. Conraads VM, Denollet J, De Clerck LS, Stevens WJ, Bridts C, Vrints CJ (2006). Type D personality is associated

with increased levels of tumour necrosis factor (TNF)-alpha and TNF-alpha receptors in chronic heart failure. INTERNATIONAL JOURNAL OF CARDIOLOGY, 113:34-38. (IF= 6.1)

150. Pedersen SS, Denollet J, Spindler H, Ong AT, Serruys PW, Erdman RA, van Domburg RT (2006). Anxiety enhances the detrimental effect of depressive symptoms on health status following percutaneous coronary intervention. JOURNAL

OF PSYCHOSOMATIC RESEARCH, 61: 783-789. (IF= 2.8)

151. Pedersen SS, Denollet J, Ong ATL, Serruys PW, Erdman RAM, van Domburg RT (2007). Impaired health status in Type D patients following PCI in the drug-eluting stent era. INTERNATIONAL JOURNAL OF CARDIOLOGY, 114:358-365. (IF= 6.1)

152. Pedersen SS, Denollet J, Ong ATL, Sonnenschein K, Erdman RAM, Serruys PW, van Domburg RT (2007). Adverse

clinical events in patients treated with sirolimus-eluting stents: the impact of Type D personality. EUROPEAN JOURNAL OF CARDIOVASCULAR PREVENTION AND REHABILITATON, 14:135-140. (IF= 2.6)

153. Kuijpers PM, Denollet J, Wellens HJ, Crijns HM, Honig A (2007). Noncardiac chest pain in the emergency department: the role of cardiac history, anxiety or depression and Type D personality. EUROPEAN JOURNAL OF CARDIOVASCULAR

PREVENTION AND REHABILITATON, 14:273-279. (IF= 2.6)

154. Pedersen SS, Denollet J, Daemen J, van de Sande M, de Jaegere PT, Serruys PW, Erdman RA, van Domburg RT

(2007). Fatigue, depressive symptoms, and hopelessness as predictors of adverse clinical events following percutaneous coronary intervention with paclitaxel-eluting stents. JOURNAL OF PSYCHOSOMATIC RESEARCH, 62:455-461. (IF= 2.8)

155. Schiffer AA, Denollet J, Widdershoven JW, Hendriks EH, Smith OR (2007). Failure to consult for symptoms of heart failure in patients with a Type D personality. HEART, 93:814-818. (IF= 6.0)


156. Aquarius AE, Denollet J, Hamming JF, Van Berge Henegouwen DP, De Vries J (2007). Type D personality and ankle-brachial index as predictors of impaired quality of life and depressive symptoms in peripheral arterial disease. ARCHIVES

OF SURGERY, 142:662-667. (IF= 4.2)

157. Aquarius EE, Denollet J, de Vries J, Hamming JF (2007). Poor health-related quality of life in patients with peripheral arterial disease: Type D personality and severity of peripheral arterial disease as independent predictors. JOURNAL OF

VASCULAR SURGERY, 46:507-512. (IF= 2.9)

158. de Jonge P, Denollet J, van Melle JP, Kuyper A, Honig A, Schene AH, Ormel J (2007). Associations of Type D personality and depression with somatic health in myocardial infarction patients. JOURNAL OF PSYCHOSOMATIC

RESEARCH, 63:477-482. (IF= 2.8)

159. De Valck CF, Denollet J, Wuyts FL, Van De Heyning PH (2007). Increased handicap in vertigo patients with a Type D personality. AUDIOLOGICAL MEDICINE, 5: 169-175. ( (IF= - )

160. Kupper N, Denollet J, de Geus EJC, Boomsma DI, Willemsen G (2007). Heritability of Type D personality. PSYCHOSOMATIC MEDICINE, 69:675-681. (IF= 4.0)

161. Schiffer AA, Denollet J, Pedersen SS, Broers H, Widdershoven JW (2008). Health status in patients treated with cardiac resynchronization therapy: modulating effects of personality. PACING AND CLINICAL ELECTROPHYSIOLOGY, 31:28–37. (IF= 1.2)

162. Pedersen SS, Denollet J, van Gestel YR, Serruys PW, van Domburg RT (2008). Clustering of psychosocial risk factors enhances the risk of depressive symptoms 12-months postpercutaneous coronary intervention. EUROPEAN

JOURNAL OF CARDIOVASCULAR PREVENTION AND REHABILITATON, 15: 203-209. (IF= 2.6)

163. Beckers PJ, Denollet J, Possemiers NM, Wuyts FL, Vrints CJ, Conraads VM (2008). Combined endurance-

resistance training vs. endurance training in patients with chronic heart failure: a prospective randomized study. EUROPEAN HEART JOURNAL, 29:1858-1866. (IF=14.7)

164. Pelle AJ, Denollet J, Zwisler AD, Pedersen SS (2009). Overlap and distinctiveness of psychological risk factors in patients with ischemic heart disease and chronic heart failure: Are we there yet? JOURNAL OF AFFECTIVE

DISORDERS, 113:150-156. (IF=3.7)

165. Pedersen SS, Denollet J, de Jonge P, Simsek C, Serruys PW, van Domburg RT (2009). Brief Depression

screening with the PHQ-2 associated with prognosis following percutaneous coronary intervention with paclitaxel-eluting stenting. JOURNAL OF GENERAL INTERNAL MEDICINE, 24:1037-1042. (IF=3.4)

166. Mommersteeg PM, Denollet J, Spertus JA, Pedersen SS (2009). Health status as a risk factor in cardiovascular disease: a systematic review of current evidence. AMERICAN HEART JOURNAL, 157:208-218. (IF=4.5)

167. Spindler H, Denollet J, Kruse C, Pedersen SS (2009). Positive affect and negative affect correlate differently with

distress and health-related quality of life in patients with cardiac conditions: validation of the Danish Global Mood Scale. JOURNAL OF PSYCHOSOMATIC RESEARCH, 67:57-65. (IF=2.8)

168. Pedersen SS, Denollet J, Erdman RA, Serruys PW, van Domburg RT (2009).Co-occurrence of diabetes and

hopelessness predicts adverse prognosis following percutaneous coronary intervention. JOURNAL OF BEHAVIORAL

MEDICINE, 32:294-301. (IF=2.8)

169. Smith OR, Denollet J, Schiffer AA, Kupper N, Gidron Y (2009). Patient-rated changes in fatigue over a 12-month period predict poor outcome in chronic heart failure. EUROPEAN JOURNAL OF HEART FAILURE, 11:400-405. (IF= 6.5)

170. Van Craenenbroeck EM, Denollet J, Paelinck BP, Beckers P, Possemiers N, Hoymans VY, Vrints, CJ, Conraads

VM (2009). Circulating CD34+/KDR+ endothelial progenitor cells are reduced in chronic heart failure patients as a function of Type D personality. CLINICAL SCIENCE, 117:165-172. (IF= 5.6)

171. Beckers PJ, Denollet J, Possemiers NM, Wuyts K, Vrints CJ, Conraads VM (2010). Maintaining physical fitness of patients with chronic heart failure: a randomized controlled trial. EUROPEAN JOURNAL OF CARDIOVASCULAR

PREVENTION AND REHABILITATION, 17:660-700. (IF= 2.6)

172. Mommersteeg PM, Denollet J, Kavelaars A, Geuze E, Vermetten E, Heijnen CJ (2011). Type D personality, temperament, and mental health in military personnel awaiting deployment. INTERNATIONAL JOURNAL OF BEHAVIORAL

MEDICINE, 18:131-138. (IF= 2.2)

173. Zohar AH, Denollet J, Ari LL, Cloninger CR (2011). The psychometric properties of the DS14 in Hebrew and the

prevalence of Type D personality in Israeli adults. EUROPEAN JOURNAL OF PSYCHOLOGICAL ASSESSMENT, 27:274–281. (IF= 1.2)

174. Kret ME, Denollet J, Grèzes J, de Gelder B (2011). The role of negative affectivity and social inhibition in perceiving social threat: an fMRI study. NEUROPSYCHOLOGIA, 49:1187-1193. (IF= 3.4)

175. Kessing D, Denollet J, Widdershoven J, Kupper N (2011). Investigating a TELEmedicine solution to improve

MEDication adherence in chronic Heart Failure (TELEMED-HF): study protocol for a randomized controlled trial. TRIALS, 12:227. (IF= 2.1)

176. Brouwers C, Denollet J, de Jonge N, Caliskan K, Kealy J, Pedersen SS (2011). Patient-reported outcomes in left

ventricular assist device therapy: a systematic review and recommendations for clinical research and practice. CIRCULATION HEART FAILURE, 4:714-723. (IF=5.9)


177. Mommersteeg PM, Denollet J, Martens EJ (2012). Type D personality, depressive symptoms and work-related health outcomes. SCANDINAVIAN JOURNAL OF PUBLIC HEALTH, 40:35-42. (IF= 3.1)

178. van Bon-Martens MJ, Denollet J, Kiemeney LA, Droomers M, Beer MJ, Goor IA, Oers HA (2012). Health inequalities in the Netherlands: a cross-sectional study of the role of Type D (distressed) personality. BMC PUBLIC

HEALTH. 2012;12(1):46. (IF= 2.3)

179. Conraads VM, Denollet J, De Maeyer C, Van Craenenbroeck E, Verheyen J, Beckers P (2012). Exercise training as an essential component of cardiac rehabilitation. HEART, 98:674-675. (IF=6.0)

180. Mols F, Denollet J, Kaptein AA, Reemst PH, Thong MS (2012). The association between Type D personality and illness perceptions in colorectal cancer survivors: A study from the population-based PROFILES registry. JOURNAL

OF PSYCHOSOMATIC RESEARCH, 73:232-239. (IF= 2.8)

181. Hoen PW, Denollet J, de Jonge P, Whooley MA (2013). Positive affect and survival in patients with stable coronary heart disease: Findings from the Heart and Soul Study. JOURNAL OF CLINICAL PSYCHIATRY, 74:716-722. (IF= 5.1)

182. Husson O, Denollet J, Oerlemans S, Mols F (2013). Satisfaction with information provision in cancer patients and the moderating effect of Type D personality. PSYCHO-ONCOLOGY, 22:2124-2132. (IF= 4.0)

183. Kupper N, Denollet J, Widdershoven JW, Kop WJ (2013). Type D personality is associated with low cardiovascular reactivity to acute mental stress in heart failure patients. INTERNATIONAL JOURNAL OF

PSYCHOPHYSIOLOGY, 90:44-49. (IF= 2.6)

184. Svansdóttir E, Denollet J, Thorson B, Gudnason T, Halldorsdottir S, Gudnason V, van den Broek KC, Karlsson

D (2013). Association of Type D personality with unhealthy lifestyle, and estimated risk of coronary events in the general Icelandic population. EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY, 20:322-330. (IF= 2.6)

185. Weng CY, Denollet J, Lin CL, Lin TK, Wang WC, Lin JJ, Wong SS, Mols F (2013). The validity of the Type D construct and its assessment in Taiwan. BMC PSYCHIATRY, 13, 46-. (IF= 2.2)

186. Habibović M, Denollet J, Cuijpers P, Spek VR, van den Broek KC, Warmerdam L, van der Voort PH, Herrman

JP, Bouwels L, Valk SS, Alings M, Theuns DA, Pedersen SS (2014). E-health to manage distress in patients with an implantable cardioverter-defibrillator: primary results of the WEBCARE trial. PSYCHOSOMATIC MEDICINE, 76:593-602. (IF= 4.0)

187. Brouwers C, Denollet J, Caliskan K, de Jonge N, Constantinescu A, Young Q, Kaan A, Pedersen SS (2015).

Psychological distress in patients with a left ventricular assist device and their partners: An exploratory study. EUROPEAN JOURNAL OF CARDIOVASCULAR NURSING, 14:53-62. (IF= 1.8)

188. Mastenbroek MH, Denollet J, Versteeg H, van den Broek KC, Theuns DA, Meine M, Zijlstra WP, Pedersen SS

(2015). Trajectories of patient-reported health status in patients with an implantable cardioverter defibrillator. AMERICAN JOURNAL OF CARDIOLOGY, 115:771-777. (IF= 3.4)

189. Kupper N, Denollet J, Widdershoven J, Kop WJ (2015). Cardiovascular reactivity to mental stress and mortality in patients with heart failure. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY-HEART FAILURE, 3:373-382. (IF= - )

190. Zitteren MV, Denollet J, Heyligers J, Elshof JW, Nooren M, Burger D, Fijter MD, Vriens P, Smolderen KG (2015).

One-year health status benefits following treatment for new-onset or exacerbation of peripheral arterial disease symptoms: the importance of patients' baseline health status. EUROPEAN JOURNAL OF VASCULAR AND ENDOVASCULAR

SURGERY, 50:213-222. (IF= 3.0)

191. Kessing D, Denollet J, Widdershoven J, Kupper N (2015). Fatigue and self-care in patients with chronic heart failure EUROPEAN JOURNAL OF CARDIOVASCULAR NURSING, 00:000-000, in press. (IF= 1.8)

OTHER AUTHOR (International refereed journals)

192. Pedersen SS, Martens EJ, Denollet J, Appels A (2007). Poor health-related quality of life is a predictor of early but not late cardiac events after percutaneous coronary intervention. PSYCHOSOMATICS, 48:331-337. (IF= 1.6)

193. Martens EJ, Smith ORF, Winter J, Denollet J, Pedersen SS (2008). Cardiac history, prior depression and personality predict course of depressive symptoms post-myocardial infarction. PSYCHOLOGICAL MEDICINE, 38: 257-264. (IF= 5.4)

194. Smolderen KG, Hoeks SE, Aquarius AE, Scholte op Reimer WJ, Spertus JA, van Urk H, Denollet J, Poldermans

D (2008). Further validation of the peripheral artery questionnaire: results from a peripheral vascular surgery survey in the Netherlands. EUROPEAN JOURNAL OF VASCULAR AND ENDOVASCULAR SURGERY, 36: 582-591. (IF= 3.0)

195. Pedersen SS, Spek V, Theuns DA, Alings M, van der Voort P, Jordaens L, Cuijpers P, Denollet J, van den Broek

KC (2009). Rationale and design of WEBCARE: a randomized, controlled, web-based behavioral intervention trial in cardioverter-defibrillator patients to reduce anxiety and device concerns and enhance quality of life. TRIALS, 10:120. (IF= 2.1)

196. Roncella A, Giornetti A, Cianfrocca C, Pasceri V, Pelliccia F, Denollet J, Pedersen SS, Speciale G, Richichi G,

Pristipino C (2009). Rationale and trial design of a randomized, controlled study on short-term psychotherapy


after acute myocardial infarction: the STEP-IN-AMI trial (Short Term Psychotherapy in Acute Myocardial Infarction. JOURNAL OF CARDIOVASCULAR MEDICINE, 10:947-952. (IF= 1.4)

197. Smolderen KG, Spertus JA, Reid KJ, Buchanan DM, Krumholz HM, Denollet J, Vaccarino V, Chan PS (2009).

The association of cognitive and somatic depressive symptoms with depression recognition and outcomes after myocardial infarction. CIRCULATION: CARDIOVASCULAR QUALITY AND OUTCOMES, 2:328-237. (IF=5.0)

198. Koopmans B, Pouwer F, de Bie RA, Leusing GL, Denollet J, Pop VJ (2009). Associations between vascular co-morbidities and depression in insulin naive diabetes patients: the DIAZOB Primary Care Diabetes study. DIABETOLOGIA, 52:2056-2063. (IF= 6.8)

199. Nefs G, Pouwer F, Denollet J, Pop VJ (2010). Psychological risk factors of micro- and macrovascular outcomes

in primary care patients with type 2 diabetes: rationale and design of the DiaDDZoB Study. BMC PUBLIC HEALTH, 10:388. (IF= 2.3)

200. Roest AM, Martens EJ, Denollet J, De Jonge P (2010). Prognostic association of anxiety post myocardial infarction with mortality and new cardiac events: a meta-analysis. PSYCHOSOMATIC MEDICINE, 72:563-569. (IF=4.0)

201. Hoen PW, Conradi HJ, Denollet J, Martens EJ, de Jonge P (2010). Interview-based ratings of somatic and cognitive symptoms of depression and their impact on cardiovascular prognosis. PSYCHOTHERAPY AND

PSYCHOSOMATICS, 79:319-320. (IF=9.3)

202. Versteeg H, Baumert J, Kolb C, Pedersen SS, Denollet J, Ronel J, Ladwig KH (2010). Somatosensory amplification mediates sex differences in psychological distress among cardioverter-defibrillator patients. HEALTH

PSYCHOLOGY, 29:477-830. (IF=3.9)

203. Smith OR, Kupper N, Denollet J, de Jonge P (2011). Vital exhaustion and cardiovascular prognosis in myocardial infarction and heart failure: predictive power of different trajectories. PSYCHOLOGICAL MEDICINE, 41(4):731-738. (IF=5.4)

204. Kupper N, Boomsma DI, de Geus EJ, Denollet J, Willemsen G (2011). Nine-year stability of type D personality: contributions of genes and environment. PSYCHOSOMATIC MEDICINE, 73:75-82. (IF= 4.0)

205. Pedersen SS, Versteeg H, Denollet J, Cheng JM, Serruys PW, van Domburg RT (2011). Patient-rated health status predicts prognosis following percutaneous coronary intervention with drug-eluting stenting. QUALITY OF LIFE

RESEARCH, 20:559-567. (IF=2.8)

206. Brouwers C, van den Broek KC, Denollet J, Pedersen SS (2011). Gender disparities in psychological distress and quality of life among patients with an implantable cardioverter defibrillator. PACING AND CLINICAL

ELECTROPHYSIOLOGY, 34:798-803. (IF=1.2)

207. van de Poll-Franse LV, Horevoorts N, van Eenbergen M, Denollet J, Roukema JA, Aaronson NK, Vingerhoets A,

Coebergh JW, de Vries J, Essink-Bot ML, Mols F; Profiles Registry Group (2011). The Patient Reported Outcomes Following Initial treatment and Long term Evaluation of Survivorship (PROFILES) registry: scope, rationale and design of an infrastructure for the study of physical and psychosocial outcomes in cancer survivorship cohorts. EUROPEAN JOURNAL OF CANCER, 47:2188-2894. (IF=4.8)

208. Grynberg D, Gidron Y, Denollet J, Luminet O (2012). Evidence for a cognitive bias of interpretation toward threat in individuals with a Type D personality. JOURNAL OF BEHAVIORAL MEDICINE, 35:95-102. (IF= 2.8)

209. Mommersteeg PM, Pelle AJ, Ramakers C, Szabó BM, Denollet J, Kupper N. Type D personality and course of

health status over 18 months in outpatients with heart failure: Multiple mediating inflammatory biomarkers (2012). BRAIN, BEHAVIOR AND IMMUNITY, 26:301-310. (IF= 6.1)

210. Van Craenenbroeck EM, Pelle AJ, Beckers PJ, Possemiers NM, Ramakers C, Vrints CJ, Van Hoof V, Denollet J, Conraads VM (2012). Red cell distribution width as a marker of impaired exercise tolerance in patients with chronic heart failure. EUROPEAN JOURNAL OF HEART FAILURE, 14:54-60. (IF= 6.5)

211. Nefs G, Pouwer F, Denollet J, Pop V (2012). The course of depressive symptoms in primary care patients with

type 2 diabetes: results from the Diabetes, Depression, Type D Personality Zuidoost-Brabant (DiaDDZoB) Study. DIABETOLOGIA, 55:608-616. (IF= 6.8)

212. Pommer AM, Pouwer F, Denollet J, Pop VJ (2012). Managing co-morbid depression and anxiety in primary care

patients with asthma and/or chronic obstructive pulmonary disease: study protocol for a randomized controlled trial. TRIALS, 13:6. (IF= 2.1)

213. Versteeg H, Starrenburg A, Denollet J, Palen JV, Sears SF, Pedersen SS (2012). Monitoring device acceptance in implantable cardioverter defibrillator patients using the Florida Patient Acceptance Survey. PACING AND CLINICAL

ELECTROPHYSIOLOGY, 35:283-293. (IF= 1.2)

214. van Zitteren M, Vriens PW, Heyligers JM, Burger DH, Nooren MJ, de Fijter WM, Denollet J, Smolderen KG

(2012). Self-reported symptoms on questionnaires and anatomic lesions on duplex ultrasound examinations in patients with peripheral arterial disease. JOURNAL OF VASCULAR SURGERY, 55:1025-1034. (IF= 2.9)

215. Mols F, Oerlemans S, Denollet J, Roukema JA, van de Poll-Franse LV (2012). Type D personality is associated

with increased comorbidity burden and health care utilization among 3080 cancer survivors. GENERAL HOSPITAL

PSYCHIATRY, 34:352-359. (IF= 2.8)

216. Nefs G, Pouwer F, Denollet J, Kramer H, Wijnands-van Gent CJ, Pop VJ (2012). Suboptimal glycemic control in type 2 diabetes: A key role for anhedonia? JOURNAL OF PSYCHIATRIC RESEARCH, 46:549-454. (IF= 4.0)


217. Conraads VM, Van Craenenbroeck EM, Pattyn N, Cornelissen VA, Beckers PJ, Coeckelberghs E, De Maeyer C, Denollet J, Frederix G, Goetschalckx K, Hoymans VY, Possemiers N, Schepers D, Shivalkar B, Vanhees L

(2013). Rationale and design of a randomized trial on the effectiveness of aerobic interval training in patients with coronary artery disease: the SAINTEX-CAD study. INTERNATIONAL JOURNAL OF CARDIOLOGY, 168:3532-3526. (IF= 6.1)

218. Damen NL, Versteeg H, Boersma E, Serruys PW, van Geuns RJ, Denollet J, van Domburg RT, Pedersen SS

(2013). Depression is independently associated with 7-year mortality in patients treated with percutaneous coronary intervention: the RESEARCH registry. INTERNATIONAL JOURNAL OF CARDIOLOGY, 167:2496-2501. (IF= 6.1)

219. Dieltjens M, Vanderveken OM, Van Den Bosch D, Wouters K, Denollet J, Verbraecken JA, Van De Heyning PH,

Braem MJ (2013). Impact of type D personality on adherence to oral appliance therapy for sleep-disordered breathing. SLEEP AND BREATHING, 17:985-991. (IF= 2.8)

220. Meijer A, Conradi HJ, Bos EH, Anselmino M, Carney RM, Denollet J, Doyle F, Freedland KE, Grace SL, Hosseini

SH, Lane DA, Pilote L, Parakh K, Rafanelli C, Sato H, Steeds RP, Welin C, de Jonge P (2013). Adjusted prognostic association of depression following myocardial infarction with mortality and cardiovascular events: Individual patient data meta-analysis. BRITISH JOURNAL OF PSYCHIATRY, 203:90-102. (IF= 7.3)

221. Mommersteeg PM, Pot I, Aamoudse W, Denollet J, Widdershoven JW (2013). Type D personality and patient-

perceived health in nonsignificant coronary artery disease: The TWeesteden mIld STenosis (TWIST) study. QUALITY OF LIFE RESEARCH, 22:2041-2050. (IF= 2.8)

222. Nefs GM, Pop VJ, Denollet J, Pouwer F (2013). The longitudinal association between depressive symptoms and initiation of insulin therapy in people with Type 2 diabetes in primary care. PLOS ONE, 8(11) e78865. (IF=3.5)

223. Roest AM, Carney RM, Freedland KE, Martens EJ, Denollet J, de Jonge P (2013). Changes incognitive versus

somatic symptoms of depression and event-free survival following acute myocardial infarction in the Enhancing Recovery In Coronary Heart Disease (ENRICHD) study. JOURNAL OF AFFECTIVE DISORDERS, 149:335-341. (IF= 3.7)

224. Roncella A, Pristipino C, Cianfrocca C, Scorza S, Pasceri V, Pelliccia F, Denollet J, Pedersen SS, Speciale G

(2013). One-year results of the randomized, controlled, short-term psychotherapy in acute myocardial infarction (STEP-IN-AMI) trial. INTERNATIONAL JOURNAL OF CARDIOLOGY, 170:132-139. (IF= 6.1)

225. van Dooren FE, Nefs GM, Schram MT, Verhey FR, Denollet J, Pouwer F (2013). Depression and risk of mortality in people with diabetes mellitus: A systematic review and meta-analysis. PLOS ONE, 2013;8(3):e57058-. (IF= 3.5)

226. Widdershoven JW, Kessing DE, Schiffer AA, Denollet J, Kupper N. (2013). How are depression and Type D personality associated with outcomes in chronic heartf failure patients? CURRENT HEART FAILURE REPORTS, 10: 244-253. (IF= - )

227. Pommer AM, Pouwer F, Denollet J, Meijer JW, Pop VJ (2014). Patient-reported outcomes in primary care patients

with COPD: psychometric properties and usefulness of the Clinical COPD Questionnaire (CCQ). A cross-sectional study. NPJ PRIM CARE RESPIR MED, 2014 Jul 17; 24:14027. (IF= 2.9)

228. Mommersteeg PM, Meeuwis SH, Denollet J, Widdershoven JW, Aarnoudse W, Westerhuis BL, Kop WJ (2014).

C-reactive protein and fibrinogen in non-obstructive coronary artery disease as related to depressive symptoms and anxiety: Findings from the TweeSteden Mild Stenosis Study (TWIST). JOURNAL OF PSYCHOSOMATIC RESEARCH, 77:426-429. (IF= 2.8)

229. van den Broek KC, Kupper N, van der Voort PH, Alings M, Denollet J, Nyklíček I (2014). Trajectories of perceived emotional and physical distress in patients with an implantable cardioverter defibrillator. INTERNATIONAL JOURNAL OF

BEHAVIORAL MEDICINE, 21:149-159. (IF= 2.2)

230. van Loo HM, van den Heuvel ER, Schoevers RA, Anselmino M, Carney RM, Denollet J, Doyle F, Freedland KE,

Grace SL, Hosseini SH, Parakh K, Pilote L, Rafanelli C, Roest AM, Sato H, Steeds RP, Kessler RC, de Jonge P (2014). Sex dependent risk factors for mortality after myocardial infarction: individual patient data meta-analysis. BMC MEDICINE, 17;12(1):242. (IF= 7.2)

231. Brouwers C, de Jonge N, Caliskan K, Manintveld O, Young QR, Kaan A, Kealy J, Denollet J, Pedersen SS (2014).

Predictors of changes in health status between and within patients 12 months post left ventricular assist device implantation. EUROPEAN JOURNAL OF HEART FAILURE, 16:566-573. (IF= 6.5)

232. Dreyer RP, van Zitteren M, Beltrame JF, Fitridge R, Denollet J, Vriens PW, Spertus JA, Smolderen KG (2014).

Gender differences in health status and adverse outcomes among patients with peripheral arterial disease. JOURNAL OF THE AMERICAN HEART ASSOCIATION, 23:4(1). (IF= 2.8)

233. Conraads VM, Pattyn N, De Maeyer C, Beckers PJ, Coeckelberghs E, Cornelissen VA, Denollet J, Frederix G,

Goetschalckx K, Hoymans VY, Possemiers N, Schepers D, Shivalkar B, Voigt JU, Van Craenenbroeck EM, Vanhees L (2015). Aerobic interval training and continuous training equally improve aerobic exercise capacity in patients with coronary artery disease: The SAINTEX-CAD study. INTERNATIONAL JOURNAL OF CARDIOLOGY, 179:203-210. (IF= 6.1)

234. Brouwers C, Caliskan K, de Jonge N, Theuns DA, Constantinescu A, Young QR, Cannon C, Denollet J, Pedersen

SS (2015). A comparison of the health status and psychological distress of partners of patients with a left ventricular assist device versus an implantable cardioverter defibrillator. HEART & LUNG, 44:27-32. (IF= 1.3)


235. Husson O, Vissers PA, Denollet J, Mols F (2015). The role of personality in the course of health-related quality

of life and disease-specific health status among colorectal cancer survivors; a prospective population-based study from the PROFILES registry. ACTA ONCOLOGICA, 54:669-677. (IF= 3.7)

236. Tully PJ, Winefield HR, Baker RA, Denollet J, Pedersen SS, Wittert GA, Turnbull DA (2015). Depression, anxiety

and major adverse cardiovascular and cerebrovascular events in patients following coronary artery bypass graft surgery: a five year longitudinal cohort study. BIOPSYCHOSOCIAL MEDICINE, 26;9:14. doi: 10.1186/s13030-015-0041-5. (IF= - )

237. Naudé PJ, Mommersteeg PM, Gouweleeuw L, Eisel UL, Denollet J, Westerhuis LW, Schoemaker RG (2015).

NGAL and other markers of inflammation as competitive or complementary markers for depressive symptom dimensions in heart failure. WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY, 00:000-000, in press. (IF= 4.1)

238. Nefs G, Pop VJ, Denollet J, Pouwer F (2015). Depressive symptom clusters differentially predict cardiovascular hospitalization in people with type 2 diabetes. PSYCHOSOMATICS, 00:000-000, in press. (IF= 1.8)

239. Nefs G, Pop VJ, Denollet J, Pouwer F (2015). Depressive symptoms and all-cause mortality in people with type 2 diabetes: a focus on potential mechanisms. BRITISH JOURNAL OF PSYCHIATRY, 00:000-000, in press. (IF= 7.3)

Book chapters and professional publications (international)

240. Boudrez H, Denollet J, Amsel B, et al. (1992). Psychological status of patients before and after coronary bypass. In Walter P. (ed.): “QUALITY OF LIFE AFTER OPEN HEART SURGERY”, Dordrecht: Kluwer, pp 169-176.

241. Denollet J (1997b). Non-expression of negative emotions as a personality feature in coronary patients. In Vingerhoets A., Van Bussel F. & Boelhouwer J. (eds.): “THE(NON)EXPRESSION OF EMOTIONS IN HEALTH AND DISEASE”, Tilburg: Tilburg University Press, pp. 183-192.

242. Denollet J & Nyklíček I (2004). Psychological mindedness: A new index to assess a major emotion-focused coping style. In: Nyklíček I, Temoshok L & Vingerhoets A. (eds.): “Emotional EXPRESSION AND HEALTH”, New York,NY: Brunner-Routledge, pp. 185-203.

243. Vingerhoets AF, Nyklíček I, Denollet J (Eds). EMOTION REGULATION: CONCEPTUAL AND CLINICAL ISSUES. Berlin/New

York: Springer, 2007 (ISBN: 978-0-387-29985-3).

244. Denollet J, Nyklíček I, Vingerhoets AF (2007). Emotions, emotion regulation, and health: Introduction. In: Vingerhoets A, Nyklíček I, Denollet J (Eds.) . (Eds.) . EMOTION REGULATION: CONCEPTUAL AND CLINICAL ISSUES. Berlin/New York: Springer, 2007 (ISBN: 978-0-387-29985-3), pp 1-11.

245. Denollet J, Kupper H. (2008) Potential mechanisms that may explain adverse health outcomes in patients with a Type D personality. In: Sher L. (Ed.) PSYCHOLOGICAL FACTORS AND CARDIOVASCULAR DISORDERS. New York,NY: Nova

Science Publishers, Inc., 2008 (ISBN 978-1-60456-871-4), pp. 241-259.

246. Pedersen SS, Kupper H, Denollet J (2009). Psychological factors and heart disease (Chapter 37). In: Camm J,

Lüscher T & Serruys P (eds.): THE ESC TEXTBOOK OF CARDIOVASCULAR MEDICINE, 2ND ED. Oxford University Press.

247. Denollet J (2010). At the interface between mind and body: Emotion and heart disease, fact or fiction? PUBLIC

SCIENCE REVIEW, Science & Technology 07.

248. Denollet J., Pedersen SS (2011). Type D personality in patients with cardiovascular disorder (Chapter 9). In: Allen

R., Fisher J (Eds.), HEART AND MIND II. Washington,DC: American Psychological Association.

249. Denollet J (2011). Learning to adjust (editorial). PUBLIC SCIENCE REVIEW, Science & Technology 10.

250. Denollet J (2011). The interface between medicine and behavioral sciences). PUBLIC SCIENCE REVIEW, Science &

Technology 10.

251. Pelle AJ, van den Broek KC, Denollet J (2012). Interventions in the context of the distressed (Type D) personality. In: Dornelas EA (Ed.): STRESS PROOF THE HEART: BEHAVIORAL INTERVENTIONS FOR CARDIAC PATIENTS. New York:

Springer, 2012, pp. 167-197.

252. Denollet J (2012). Type D or not Type D: that’s the question. THE EUROPEAN HEALTH PSYCHOLOGIST, 14:58-63.

253. Denollet J (2013). Negative Affectivity. In Gellman MD & Turner JR (Eds.), ENCYCLOPEDIA OF BEHAVIORAL MEDICINE

(pp.1304-1305). New York: Springer.

254. Denollet J (2013). Social Inhibition. In Gellman MD & Turner JR (Eds.), ENCYCLOPEDIA OF BEHAVIORAL MEDICINE


255. Denollet J (2013). Type D Personality. In Gellman MD & Turner JR (Eds.), ENCYCLOPEDIA OF BEHAVIORAL MEDICINE


National publications in refereed journals and books (in Dutch)

256. Denollet J (1981). Het MBD-syndroom: Behandeling en prognose. KIND EN ADOLESCENT, 2:199-211.


257. Denollet J (1982). MBD, kinderen met lichte stoornissen in de hersenfunctie. TIJDSCHRIFT VOOR ORTHOPEDAGOGIEK,

21:219-238.

258. Denollet J (1983). Biologische achtergronden van het hyperkinetisch syndroom. TIJDSCHRIFT VOOR

KINDERGENEESKUNDE, 51:37-51.

259. Vaes JC, Denollet J, Beckers P & Gillebert TC (1995). Multidisciplinaire revalidatie van hartpatiënten: Verantwoorde investering of overbodige luxe ? TIJDSCHRIFT VOOR GENEESKUNDE, 51:781-794.

260. Denollet J (1997). Depressiviteit en coronair hartlijden. In Demyttenaere K & Reynaert C (eds.): “DEPRESSIE &

PSYCHOSOMATIEK”, Leuven/Apeldoorn: Garant, pp. 177-192.

261. Stroobant N, Denollet J, De Bourdeaudhuij I & Van Oost P (1998). Persoonlijkheid en mortaliteit bij coronair hartlijden. GEDRAG & GEZONDHEID, 26:27-38.

262. Verwaal I, van der Voort P, Denollet J (2004). Cardiovasculaire aandoeningen. In Pool G, Heuvel F, Ranchor AV &

Sanderman R (eds.): HANDBOEK PSYCHOLOGISCHE INTERVENTIES BIJ CHRONISCH-SOMATISCHE AANDOENINGEN. Assen: Koninklijke Van Gorcum, pp 511-520.

263. Verhaegen M, Denollet J (2004). Acuut myocardinfarct -casuÏstiek. In Pool G, Heuvel F, Ranchor AV & Sanderman R (eds.): HANDBOEK PSYCHOLOGISCHE INTERVENTIES BIJ CHRONISCH-SOMATISCHE AANDOENINGEn. Assen: Koninklijke Van Gorcum, pp 603-616.

264. Denollet J, Aquarius A, Smolderen K (2006). Ischemische hart- en vaatziekten. In: Kaptein e.a. (eds.): PSYCHOLOGIE

EN GENEESKUNDE, Houten/Diegem: Bohn Stafleu Van Loghum, pp. 95-114.

265. Denollet J, Pelle AJ (2010). Luisteren naar het hart: Emoties, persoonlijkheid en hartziekten (Hoofdtuk 11). In: Luyten P, Vandenberghe J, Van Houdenhove B (Eds): LUISTEREN NAAR HET LICHAAM - HET DUALISME VOORBIJ. Tielt, Belgium: Uitgeverij Lannoo.

Lectures and presentations at meetings

KEYNOTE ADDRESS /INVITED LECTURE AT INTERNATIONAL MEETING

266. Denollet J (1993, September). Investigating the effect of cardiac rehabilitation on quality of life: The issue of outcome

assessment. Invited Lecture presented at THE 7TH CONFERENCE OF THE EUROPEAN HEALTH PSYCHOLOGY SOCIETY, Brussels, Belgium.

267. Denollet J (1996, March). Measurement of well-being and perceived health in outpatient cardiac rehabilitation. Invited

Lecture presented at THE 4TH INTERNATIONAL CONGRESS OF BEHAVIORAL MEDICINE, Washington,DC, USA.

268. Denollet J (1996, August). The non-expression of emotions as a personality feature in heart patients. Invited Lecture

presented at THE 1ST INTERNATIONAL CONFERENCE ON THE NON-EXPRESSION OF EMOTIONS IN HEALTH AND DISEASE, Tilburg, The Netherlands.

269. Denollet J (1997, November). Psychosocial stress and cardiac rehabilitation in coronary heart disease. Keynote

address given at THE INTERNATIONAL CONFERENCE ON SPORTS MEDICINE AND REHABILITATION, Tartu, Estonia.

270. Denollet J (1998, November). Personality and ischaemic heart disease. Invited Lecture presented at THE 6TH

SYMPOSIUM ON REHABILITATION AND EXERCISE TESTING, Paris, France.

271. Denollet J (1999, June). Quality of life is the major endpoint in heart failure. State-of-the-Art lecture, HEART FAILURE

'99 -THIRD INTERNATIONAL MEETING OF THE EUROPEAN SOCIETY OF CARDIOLOGY, Göteborg, Sweden.

272. Denollet J (2001, September). Cardiac psychology: More than just depression. Keynote address given at THE 15TH

CONFERENCE OF THE EUROPEAN HEALTH PSYCHOLOGY SOCIETY, St Andrews, Scotland.

273. Denollet J (2001, September). Personality and progression of coronary heart disease. Invited Lecture presented at

THE 15TH CONFERENCE OF THE EUROPEAN HEALTH PSYCHOLOGY SOCIETY, St Andrews, Scotland.

274. Denollet J (2002, January). Predictive value of Type D in coronary patients. Invited Lecture presented at 21TH ANNUAL

SCIENTIFIC MEETING OF THE BELGIAN SOCIETY OF CARDIOLOGY, Brussels, Belgium.

275. Denollet J (2002, May). Inhibition and defensiveness may moderate the effect of negative affectivity on prognosis in

coronary heart disease. Invited Lecture presented at THE 4TH DUTCH CONFERENCE ON PSYCHOLOGY & HEALTH, Kerkrade, The Netherlands.

276. Denollet J (2002, May). Reducing emotional distress and improving prognosis in coronary patients with a high-risk

personality profile. Invited Lecture presented at 4TH DUTCH CONFERENCE ON PSYCHOLOGY & HEALTH, Kerkrade, The Netherlands.

277. Denollet J (2002, October). Cardiac rehabilitation: Psychological aspects. Invited Lecture presented at YCC

SYMPOSIUM ON CARDIAC REHABILITATION, Brussels, Belgium.

278. Denollet J (2002, October). Benefits of cardiac rehabilitation in patients with chronic heart failure. Invited Lecture

presented at YCC SYMPOSIUM ON CARDIAC REHABILITATION, Brussels, Belgium.


279. Denollet J (2003, January). Distress and the heart (of the matter). Keynote address given at HEART AND MIND:

INTERNATIONAL CONFERENCE ON THE ROLE OF STRESS IN CORONARY HEART DISEASE, Maastricht, Netherlands.

280. Denollet J (2003, March). Psychosomatics and cardiology: Personality factors. Invited Lecture presented at 54TH

JAHRESTAGUNG DES DEUTSCHEN KOLLEGIUMS FÜR PSYCHOSOMATISCHEN MEDIZIN, Göttingen, Germany.

281. Denollet J (2003, June). Psychological risk factors in heart failure. Invited Lecture presented at HEART FAILURE 2003 -

INTERNATIONAL MEETING OF THE EUROPEAN SOCIETY OF CARDIOLOGY, Strassbourg, France.

282. Denollet J (2004, June). Type D personality in perspective. Invited Lecture presented at THE 25TH EUROPEAN

CONFERENCE ON PSYCHOSOMATIC RESEARCH, Berlin, Germany.

283. Denollet J (2005, April). Personality and prognosis. Keynote address given at THE 2005 SPRING MEETING OF THE

WORKING GROUP ON PREVENTION AND REHABILITATION OF THE EUROPEAN SOCIETY OF CARDIOLOGY, Leuven, Belgium.

284. Denollet J (2005, September). Type D personality: newly identified with a poor prognosis. Invited Lecture

presented at the 2005 ANNUAL MEETING OF THE EUROPEAN SOCIETY OF CARDIOLOGY, Stockholm, Sweden.

285. Denollet J (2005, October). The brain-heart axis: where is the person?. Invited Lecture presented at the 18TH MEETING

OF THE EUROPEAN COLLEGE OF NEURO-PSYCHOPHARMACOLOGY, Amsterdam, The Netherlands.

286. Denollet J (2006, June). Personality and prognosis in heart failure. Invited Lecture presented at THE 2006 HEART

FAILURE MEETING OF THE EUROPEAN SOCIETY OF CARDIOLOGY, Helsinki, Finland.

287. Denollet J (2006, September). Type D personality as a worst case scenario? Invited Lecture presented at THE WORLD

CONGRESS OF CARDIOLOGY 2006, Barcelona, Spain.

288. Denollet J (2007, June). Chronic stress related to social inhibition and negative affectivity: The ABC of Type-D.

Invited Lecture presented at THE 34TH ANNUAL MEETING OF THE GERMAN REHABILITATION CARDIOLOGY SOCIETY, Berlin, Germany.

289. Denollet J (2008, November). Towards person-related cardiac care: Weighing the evidence on Type D personality.

Keynote address given at THE 2ND ASIAN PREVENTIVE CARDIOLOGY AND CARDIAC REHABILITATION CONFERENCE, Hong Kong, China.

290. Denollet J (2010, August). Disentangling the influences of mood and personality on cardiovascular health. Invited

Lecture presented at THE EUROPEAN SOCIETY OF CARDIOLOGY 2010 MEETING, Stockholm, Sweden.

291. Denollet J (2010, September). Personality: Impact on heart disease and treatment. Invited Lecture presented at THE

5TH ANNUAL HEART-BRAIN SUMMIT, Cleveland Clinic, Las Vegas, USA.

292. DenolletJ (2011, March). Chronic psychological distress and interventions in patients with heart disease. Invited

Lecture presented at THE 2011 ANNUAL MEETING OF THE AMERICAN PSYCHOSOMATIC SOCIETY, San Antonio,TX, USA.

293. Denollet J (2012, August). Type D or not Type D: that’s the questione. Keynote address presented at THE 26TH

CONFERENCE OF THE EUROPEAN HEALTH PSYCHOLOGY SOCIETY (EHPS), Prague, Czech Republic, 2012.

294. DenolletJ (2013, July). Social inhibition, Type D personality, and cardiovascular outcomes. Keynote address given

at THE 2013 STRESS AND TEST ANXIETY RESEARCH (STAR) MEETING, Faro, Portugal.

PAPER PRESENTED AT INTERNATIONAL MEETING

295. Denollet J (1986, June). Psychological data in low-back pain patients treated with spinal cord stimulation. Paper

presented at THE SECOND INTERNATIONAL SYMPOSIUM: THE PAIN CLINIC, Lille, France.

296. Denollet J (1987, July). Personality assessment in chronic pain. Paper presented at THE 10TH INTERNATIONAL

CONFERENCE ON PERSONALITY ASSESSMENT, Brussels, Belgium.

297. Denollet J (1988, October). The impact of anxiety and denial on Type-A self-report and rehabilitation outcome in coronary heart disease. Paper presented at THE 4TH WORLD CONGRESS OF CARDIAC REHABILITATION, Brisbane, Australia.

298. Denollet J (1995, March). Depression and mortality after myocardial infarction: A personality effect? Paper presented

at THE 1995 ANNUAL MEETING OF THE AMERICAN PSYCHOSOMATIC SOCIETY, New Orleans,LA, USA.

299. Denollet J (1996, March). Personality and mortality in coronary heart disease. Paper presented at THE 1996 ANNUAL

MEETING OF THE AMERICAN PSYCHOSOMATIC SOCIETY, Williamsburg,VA, USA.

300. Denollet J (1996, July). Does anger kill? Paper presented at THE 8TH EUROPEAN CONFERENCE ON PERSONALITY, Ghent,

Belgium.

301. Denollet J (1999, March). Repressive coping predicts mortality in patients with coronary heart disease. Paper

presented at THE 1999 ANNUAL MEETING OF THE AMERICAN PSYCHOSOMATIC SOCIETY, Vancouver, Canada.

302. Denollet J (2000, August). Cardiac rehabilitation, negative affect, & long-term mortality. Paper presented at THE 14TH

CONFERENCE OF THE EUROPEAN HEALTH PSYCHOLOGY SOCIETY, Leiden, The Netherlands.

303. Denollet J (2001, August). Type D personality as independent predictor of adverse health outcomes. Paper presented

at THE 16TH WORLD CONGRESS ON PSYCHOSOMATIC MEDICINE, Göteborg, Sweden.


304. Denollet J (2002, March). Type D personality and vulnerability to chronic disease, impaired quality of life, and

depressive symptoms. Paper presented at THE 2002 ANNUAL MEETING OF THE AMERICAN PSYCHOSOMATIC SOCIETY, Barcelona, Spain.

305. Denollet J (2003, March). Type D personality is more than just depression: Prediction of cardiac events in 339 coronary patients. Paper presented at THE 2003 ANNUAL MEETING OF THE AMERICAN PSYCHOSOMATIC SOCIETY,

Phoenix,AZ, USA.

306. Denollet J (2004, March). Symptoms of mixed anxiety-depression and risk of clinical depression following myocardial infarction. Paper presented at THE 2004 ANNUAL MEETING OF THE AMERICAN PSYCHOSOMATIC SOCIETY, Orlando,FL, USA.

307. Denollet J (2005, March). Focus of behavioral intervention in coronary heart disease: what lies beyond depression?

Paper presented at THE 2005 ANNUAL MEETING OF THE AMERICAN PSYCHOSOMATIC SOCIETY, Vancouver,BC, Canada.

308. Denollet J (2007, March). Anxiety and premature death in women at midlife: Ten-year follow-up of 5073 healthy respondents. Paper presented at THE 2007 ANNUAL MEETING OF THE AMERICAN PSYCHOSOMATIC SOCIETY, Budapest, Hungary.

309. Denollet J (2009, November). CAD patients who suppress their anger are at increased risk of major cardiac events.

Paper presented at THE AMERICAN HEART ASSOCIATION SCIENTIFIC SESSIONS 2009, Orlando, USA.

310. Denollet J (2012, March). Prognostic importance of Type D (distressed) personality in patients with coronary artery disease. Paper presented at THE 2012 ANNUAL MEETING OF THE AMERICAN PSYCHOSOMATIC SOCIETY, Athens, Greece.

311. Denollet J (2012, March). Prognostic importance of cognitive depressive symptoms in younger versus older post-MI patients. Paper presented at THE 2012 ANNUAL MEETING OF THE AMERICAN PSYCHOSOMATIC SOCIETY, Athens,

Greece.

312. Denollet J, Kupper N (2014, March). Personality factors affecting coronary artery disease: Type D, the Five-Factor Model, and adverse events. Paper presented at THE 72ND ANNUAL MEETING OF THE AMERICAN PSYCHOSOMATIC

SOCIETY, San Francisco, CA, USA.

313. Denollet J, Habibović M, Cuijpers P, Spek VR, van den Broek KC, Warmerdam L, van der Voort PH, Herrman JP, Bouwels L, Valk SS, Alings M, Theuns AM. Pedersen SS (2015, July). WEB-based distress management program for implantable CARdioverter dEfibrillator patients (WEBCARE): Results and lessons learnt. Paper presented at THE 3RD ANNUAL SCIENTIFIC MEETING OF THE EUROPEAN ASSOCIATION OF PSYCHOSOMATIC MEDICINE, Nürnberg, Germany.

KEYNOTE/INVITED LECTURE AT NATIONAL MEETING

314. Denollet J (1987, September). Voorspelbaarheid van het effect van centrale neurostimulatie in de behandeling van chronische lage rugpijn. Voordracht, GENEESKUNDIGE DAGEN VAN ANTWERPEN, Antwerp, Belgium.

315. Denollet J (1989, December). Revalidatie van hartpatiënten. Voordracht op uitnodiging, 9E STUDIEDAG VAN DE VLAAMSE

VERENIGING VOOR GEDRAGSTHERAPIE: Lichamelijke Klachten en Zelfregulering, LimburgsUniversitair Centrum, Diepenbeek, Belgium.

316. Denollet J (1993, February). The effect of cardiac rehabilitation on quality of life in men with coronary heart disease.

12TH ANNUAL SCIENTIFIC MEETING OF THE BELGIAN SOCIETY OF CARDIOLOGY, Brussels, Belgium.

317. Denollet J (1993, February). Persoonlijkheid, revalidatie en hartziekten. Voordracht op uitnodiging, FONDS VOOR

WETENSCHAPPELIJK ONDERZOEK-Contactgroep Gezondheidspsychologie, L.U.C. Diepenbeek, Belgium.

318. Denollet J (1996, June). Prognose bij coronaire patiënten. Voordracht op uitnodiging, HUISARTSEN NAVORMINGS

INSTITUUT ANTWERPEN, Update 32: Thorax, University of Antwerp, Belgium.

319. Denollet J (1996, September). Personality and heart attack. Voordracht op uitnodiging, symposium "FACES OF LIAISON

PSYCHIATRY". University of Leuven, Belgium.

320. Denollet J (1997, October). Stress en het hart. Voordracht op uitnodiging, UNIVERSITY HOSPITAL OF ANTWERP RESEARCH

CLUB, Antwerp, Belgium.

321. Denollet J (1998, May). Leef langer met minder risico. Voordracht op uitnodiging, Congres "EQ- DE KRACHT VAN

EMOTIONELE INTELLIGENTIE", De Singel, Antwerp, Belgium.

322. Denollet J (1998, December). Emoties en hartziekte. Voordracht op uitnodiging, LOKAAL OVERLEG COMITÉ, DIENST

CARDIOLOGIE, O.L.V. Ziekenhuis Aalst, Belgium.

323. Denollet J (1999, May). Stress, persoonlijk welbevinden en gezondheid. Voordracht op uitnodiging, Congres "STRESS

OP HET WERK", Koningin Elizabethzaal, Antwerp, Belgium.

324. Denollet J (1999, May). Persoonlijkheid en hartziekten. Voordracht op uitnodiging, SYMPOSIUM PSYCHOSOMATISCHE

STOORNISSEN, University of Antwerp, Belgium.

325. Denollet J (1999, September). Health-related quality of life. Voordracht op uitnodiging, UNIVERSITY HOSPITAL OF

ANTWERP RESEARCH CLUB, Antwerp, Belgium.

326. Denollet J (2000, December). Stress en hartziekten. Voordracht op uitnodiging, SYMPOSIUM CARDIO 2001,

Hartcentrum Hasselt – Virga Jesse Ziekenhuis, Hasselt, Belgium.


327. Denollet J (2000, November). Psychologische effecten van hartrevalidatie. Voordracht op uitnodiging, STUDIEDAG

SOCIETY OF PSYCHOSOMATIC MEDICINE, University of Tilburg, The Netherlands.

328. Denollet J (2000, November). Psychologische risicofactoren bij coronair hartlijden en hartfalen. Voordracht op

uitnodiging, STAF CARDIOLOGIE (prof. dr. H. Wellens), University Hospital of Maastricht, The Netherlands.

329. Denollet J (2001, May). Effectmeting bij hartrevalidatie. Voordracht op uitnodiging, Studiedag “ALLES MOET GEMETEN

WORDEN”, Sectie Revalidatie van het Nederlands Instituut van Psychologen, Utrecht, The Netherlands.

330. Denollet J (2001, June). Type D persoonlijkheid als risicofactor. Voordracht op uitnodiging, STAF CARDIOLOGIE,

University Hospital of Brussels, Belgium.

331. Denollet J (2002, November). De patiënt in de medische situatie: Van lijdend voorwerp naar leidend voorwerp.

Voordracht op uitnodiging, Studiedag “THE SCIENTIST-PRACTITIONER IN EEN NETWERK” van de Sectie Psychologen Algemene/Academische Ziekenhuizen, Eindhoven, The Netherlands.

332. Denollet J (2003, October). Stress, inflammation and coronary artery disease: The role of Type D personality.

Voordracht op uitnodiging, NEDERLANDSE PSYCHOLOGENCONGRES 2003 van het Nederlands Instituut voor Psychologie, Rotterdam, The Netherlands.

333. Denollet J (2003, October). Type D personality in perspective. Voordracht op uitnodiging, 25TH UTRECHT PSYCHIATRIC

UNIVERSITY DEPARTMENT SYMPOSIUM, University Hospital of Utrecht, The Netherlands.

334. Denollet J (2004, January). Depression, personality and heart disease: State-of-the-art. Voordracht op uitnodiging,

UNIVERSITY HOSPITAL OF ANTWERP RESEARCH CLUB, Antwerp, Belgium.

335. Denollet J (2004, March). How to deal with heart failure as a patient? INVITED LECTURE, SCIENTIFIC SYMPOSIUM HEART

FAILURE CLINICS, Antwerp, Belgium.

336. Denollet J (2004, April). Hoe kan de huisarts doeltreffender optreden t.o.v. veranderingen in levensstijl? Voordracht

op uitnodiging, CONGRES 2004 WETENSCHAPPELIJKE VERENIGING VAN VLAAMSE HUISARTSEN, BRUSSELS, Belgium.

337. Denollet J (2004, May). Quality of life after cardiac surgery. Voordracht op uitnodiging, 5TH BELGIAN SURGICAL WEEK,

Ostend, Belgium.

338. Denollet J (2004, May). An alternative view on heart failure. SCIENTIFIC SYMPOSIUM CARDIOLOGY, Tilburg, The

Netherlands.

339. Denollet J (2005, November). Kwaliteit van leven bij hartpatiënten: ziektegebonden of persoonsgebonden?

NAJAARSCONFERENTIE SECTIE REVALIDATIE NEDERLANDS INSTITUUT PSYCHOLOGIE, Vught, The Netherlands.

340. Denollet J (2006, October). Why is a dedicated cardiologist not sufficient for the heart failure patient? SECOND ANNUAL

SYMPOSIUM WORKING GROUP OF HEART FAILURE AND CARDIAC FUNCTION, BELGISCHE VERENIGING VOOR CARDIOLOGIE, Brussel, UCL St. Luc, Belgium.

341. Denollet J (2007, January). De medisch psycholoog. CONFERENTIE BMS “OPLEIDEN VOOR TOEKOMSTIGE ZORG IN

BRABANT”, Eindhoven: CZE, Nederland.

342. Denollet J (2008, March). Interactie psyche en lichamelijke ziekte. SCHWEIZERCURSUS, GENEESKUNDIGE VERENIGING,

Amersfoort, The Netherlands.

343. Denollet J (2008, May). Type D persoonlijkheid en het hart. NEDERLANDSE VERENIGING VOOR CARDIOLOGIE, ACHTSTE

SYMPOSIUM ‘TOUR D’HORIZON VIII’ VAN HET CARDIOVASCULAIR ONDERWIJS INSTITUUT, Noordwijk.

344. Denollet J (2009, January). Type D personality and heart disease: much ado about nothing? Keynote Lecture, THE

SEVENTH PSYCHOLOGY & HEALTH DAY CONFERENCE, Utrecht, The Netherlands.

345. Denollet J (2010, March). Update onType D personality and heart disease. THE CARDIOVASCULAR GRAND ROUNDS,

CARDIOVASCULAR RESEARCH INSTITUTE, MAASTRICHT UNIVERSITY, Maastricht, The Netherlands.

346. Denollet J (2010, June). Persoonlijkheid en psychologische stress bij patiënten met chronisch hartfalen. CIRO,

EXPERTISECENTRUM VOOR CHRONISCH HARTFALEN, Horn, The Netherlands.

347. Denollet J (2010, June). Depressie, angst en persoonlijkheid in relatie tot hartziekten; feit of fictie? 5TH VALERIUS

SYMPOSIUM ‘SOMA EN PSYCHE’, VU Medical Center, Amsterdam.

348. Denollet J (2010, December). Emotions and heart disease: Where is the person? Voordracht op uitnodiging, GROTE

RESEARCHBESPREKING, Afdeling Psychiatrie, UMCG, Groningen, The Netherlands.

349. Denollet J (2015, May). Persoonlijkheid en hartziekten. NEDERLANDSE VERENIGING VOOR CARDIOLOGIE, VIJFTIENDE

SYMPOSIUM ‘TOUR D’HORIZON’ VAN HET CARDIOVASCULAIR ONDERWIJS INSTITUUT, Noordwijk.

OTHER CONTRIBUTIONS TO SCIENTIFIC MEETINGS

Large number of published abstracts in international journals

Large number of poster presentations at international meetings

Large number of presentations at national and local meetings

Chair of several symposia at international, national and local meetings

____________________________________________________________________________________________

prof. dr. johan denollet november 20, 1957, wilrijk, belgium corpsâ€“center of research on

Documents